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“The fuel for evolution is diversity, with natural selection leading to continuous adaptations 
and improvements in Nature’s handiwork. Organisms (and organizations) without 
this diversity are doomed to extinction in a rapidly changing world.” 
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Arsenic, a potent toxicant and carcinogen, is naturally present in soil and leaches into 
groundwater. More than 140 million people worldwide are exposed to arsenic through drinking 
water. How well humans metabolize arsenic is a susceptibility factor for arsenic toxicity: 
individuals with a less efficient arsenic metabolism are at higher risk of arsenic-related health 
effects, such as cancer or cardiovascular disease. In fact, positive selection of a more efficient 
arsenic metabolism phenotype has been described in the Argentinean Andes, where indigenous 
populations have been presumably exposed to arsenic for centuries. However, whether this 
genetic adaptation to arsenic has occurred elsewhere in the Andes was not clear. 
The overall aim of this thesis was to assess the exposure, toxicity, and potential genetic 
adaptation to arsenic in the Bolivian Andes. For this, we recruited indigenous women from the 
Bolivian Andes living in 10 villages around Lake Poopó. 
In Paper I, we described that these Bolivian women were exposed to arsenic with varying 
arsenic concentrations in urine (range 12–407 µg/L, median 65 µg/L). The women had on 
average an efficient arsenic metabolism compared to other populations across the world. 
Ethnicity, body weight, fish consumption, and tobacco smoking were identified as influencing 
their capacity to metabolize arsenic. 
We then showed that these Bolivian women had molecular signs of arsenic toxicity by 
measuring four toxicity biomarkers in Paper II. Using multivariable-adjusted linear regression 
models, arsenic exposure was associated with longer telomeres and more copies of 
mitochondrial DNA in blood, two biomarkers for cancer risk, particularly in women with a less 
efficient arsenic metabolism. Urinary 4-hydroxy nonenal mercapturic acid, a metabolite of lipid 
peroxidation, was associated with increasing arsenic exposure. Urinary 8-oxo-2'-
deoxyguanosine, a biomarker of oxidative DNA damage, showed discrepant results depending 
on the biomarker of exposure used: a positive association with urinary arsenic vs. a negative 
association with blood arsenic. 
In Paper III, we found four putative cancer-related proteins in urine that were associated with 
arsenic exposure in blood: tumor necrosis factor ligand superfamily member 6, FASLG; 
seizure 6-like protein, SEZ6L; Ly6/PLAUR domain-containing protein 3, LYPD3; and tissue 
factor pathway inhibitor 2, TFPI2. Other factors influencing the variation of these proteins in 
urine were identified, including urinary osmolality, leukocytes in urine, and age. 
By combining genotype-phenotype association analyses and genome-wide selection scans for 
positive selection in Paper IV, we identified genetic signatures of positive selection near 
AS3MT, the main arsenic methylating enzyme, in the indigenous Bolivian study group. These 
Bolivian communities have the highest frequency of protective AS3MT alleles associated with 
a more efficient arsenic metabolism described in the literature. 
 
In conclusion, indigenous communities living in the Bolivian Andes were exposed to 
environmental arsenic and were genetically adapted to methylate arsenic more efficiently at a 
population level. Despite their efficient arsenic metabolism on average, arsenic exposure was 
still associated with toxicity biomarkers and changes in urinary cancer-related proteins, 




POPULAR SCIENCE SUMMARY 
The Andes Mountains are one of the most extreme and harsh environments that humans 
inhabit. Humans have had to adapt over generations to cope with its high altitude, arid climate, 
and exposure to metals from the volcanic bedrock. Minerals rich in arsenic in the soil erode, 
and arsenic is released into drinking water sources. Exposure to arsenic during long periods 
can lead to cancer or cardiovascular disease in adults, higher child mortality and lower birth 
weight. Arsenic is eliminated from the human body with urine after it is metabolized. If the 
body is better at metabolizing and excreting arsenic, then there is less risk of it being toxic. 
Certain regions of the Andes have had extreme levels of arsenic in water for centuries. In the 
1990s, a group of indigenous women from the Argentinean Andes was described as uniquely 
efficient at metabolizing arsenic. As generations passed, those individuals who were better at 
eliminating arsenic from their bodies had a higher chance of surviving and reproducing, until 
today, where most people living in this region of Argentina are efficient at metabolizing 
arsenic. This capacity to metabolize arsenic better or worse is determined partly by genetics. 
The increase, after many generations, of genetic variants that are responsible for beneficial 
traits in a certain environment is known as “positive selection”. 
Indigenous women from the Argentinean Andes have adapted to arsenic by metabolizing it 
more efficiently. But has this adaptation occurred as well in other regions of the Andes? 
To answer this question, we invited indigenous women from the Bolivian Andes living around 
Lake Poopó to participate in our study about the exposure, toxicity, and adaptation to arsenic.  
In the first study, we analyzed how much these Bolivian women were exposed to arsenic and 
how well they could metabolize it. To do this, we measured different arsenic metabolites in 
their urine. We saw that the women living around Lake Poopó were exposed to arsenic via 
drinking water, and, on average, they were efficient at metabolizing arsenic. However, does 
arsenic still have toxic effects? 
In the second and third study, we evaluated the toxicity of arsenic in these women. Since the 
study area includes remote villages with limited access to health care, we did not have 
information about how many women developed certain diseases. Instead, we measured disease 
and toxicity indicators at a molecular level known as biomarkers in urine and blood. In the 
second study, women who were more exposed to arsenic and were less efficient arsenic 
metabolizers had higher concentrations of biomarkers related to early signs of cancer, and 
oxidative damage to DNA and lipids. In the third study, we discovered that some proteins in 
urine related to processes that lead to cancer had different levels depending on the arsenic 
exposure of the women. 
In the last study of this thesis, we found that genetic variants associated with a more efficient 
arsenic metabolism were very common in these Bolivian indigenous communities. We also 
detected signs of positive selection in their genomes related to arsenic metabolism. 
In conclusion, this thesis shows that indigenous women living in the Bolivian Andes were 
exposed to arsenic and had, on average, an efficient arsenic metabolism thanks to genetic 
adaptation after multiple generations. However, there were indications that arsenic is toxic in 




RESUMEN DE DIVULGACIÓN CIENTÍFICA 
La cordillera de los Andes es uno de los entornos más extremos y duros en los que vive el ser 
humano. A lo largo de generaciones, los humanos han tenido que adaptarse para hacer frente a 
su altura elevada, clima árido y exposición a metales del terreno volcánico. Los minerales ricos 
en arsénico en la tierra se erosionan y este elemento se libera en el agua que después es 
consumida por el ser humano. La exposición a arsénico durante largos periodos puede 
conllevar al desarrollo de cáncer o enfermedades cardiovasculares en adultos, a un incremento 
de la mortalidad infantil y a un menor peso en neonatos. El arsénico es eliminado del cuerpo 
humano a través de la orina después de ser metabolizado. Si el cuerpo puede metabolizar y 
excretar el arsénico de una manera más eficaz, entonces hay un menor riesgo de que sea tóxico. 
Ciertas regiones de los Andes han tenido en sus aguas niveles de arsénico extremadamente 
elevados durante siglos. En la década de 1990 se describió a un grupo de mujeres indígenas de 
los Andes argentinos capaz de metabolizar el arsénico de manera excepcionalmente eficaz. A 
medida que pasaban las generaciones, aquellas personas que podían eliminar mejor el arsénico 
tenían una mayor probabilidad de sobrevivir y reproducirse, hasta la actualidad, en la que la 
mayoría de las personas que viven en esta región de Argentina metabolizan el arsénico de forma 
eficaz. Esta distinta capacidad de metabolizar el arsénico está determinada, en parte, por la 
genética. El incremento de variantes genéticas de características ventajosas tras generaciones 
se conoce como “selección positiva”. 
Las mujeres indígenas de los Andes argentinos se han adaptado para metabolizar el arsénico 
de manera más eficaz. Sin embargo, ¿ha ocurrido también esta adaptación en otras regiones de 
los Andes? Para contestar a esta pregunta, invitamos a mujeres indígenas de los Andes 
bolivianos que vivían alrededor del lago Poopó a participar en nuestro estudio sobre la 
exposición, toxicidad y adaptación al arsénico. 
En el primer estudio analizamos el grado de exposición y la capacidad de metabolización del 
arsénico de estas mujeres bolivianas. Para ello, medimos distintos metabolitos de arsénico en 
su orina. Se vio que las mujeres que vivían alrededor del lago Poopó estaban expuestas a 
arsénico a través del agua que consumían y, en promedio, podían metabolizar eficazmente el 
arsénico. A pesar de ello, ¿sigue teniendo el arsénico efectos tóxicos? 
En el segundo y tercer estudio evaluamos la toxicidad del arsénico en estas mujeres. Al incluir 
esta zona pueblos remotos con acceso limitado a servicios de salud, no teníamos información 
acerca de cuántas mujeres desarrollaron ciertas enfermedades. En vez de eso, medimos 
indicadores de enfermedad y toxicidad a nivel molecular conocidos como biomarcadores en 
orina y sangre. En el segundo estudio, las mujeres que estaban más expuestas a arsénico y lo 
metabolizaban de manera menos eficaz tenían concentraciones más elevadas de marcadores 
relacionados con signos tempranos de cáncer y de daño oxidativo al ADN y lípidos. En el tercer 
estudio descubrimos que algunas proteínas en orina relacionadas con procesos que conllevan a 
cáncer tenían niveles distintos dependiendo de la exposición a arsénico de las mujeres. 
En el último estudio de esta tesis encontramos que variantes genéticas asociadas con una mayor 
eficacia para metabolizar el arsénico eran muy comunes en estas comunidades indígenas de 
Bolivia. También hallamos en sus genomas signos de selección positiva relacionados con el 
metabolismo de arsénico. 
En conclusión, esta tesis muestra que mujeres indígenas que viven en los Andes bolivianos 
estaban expuestas a arsénico y que, en promedio, metabolizaban el arsénico eficazmente 
gracias a la adaptación genética ocurrida durante múltiples generaciones. Sin embargo, sí que 
había signos de que el arsénico es tóxico en estas poblaciones, por lo que son necesarios más 





Bergskedjan Anderna är bland de mest extrema och ogästvänliga miljöer som människor bebor. 
Människor har behövt anpassa sig över generationer för att klara av dess höga höjder, torra 
klimat och metallrika, vulkaniska berggrund. Mineraler rika på arsenik i jorden eroderar och 
arsenik hamnar i dricksvattnet. Att exponeras för arsenik under långa perioder kan leda till 
cancer och hjärt- och kärlsjukdomar hos vuxna, samt ökad barnadödlighet och lägre 
födelsevikt. Arsenik elimineras från kroppen genom urinen efter att det har omvandlats i 
kroppen (metaboliserats). Om kroppen är bra på att metabolisera och utsöndra arsenik så 
minskar risken att det är toxiskt. 
Vissa delar av Anderna har haft extremt höga arsenikhalter i vattnet under århundraden. På 
1990-talet beskrevs en grupp kvinnor ur ursprungsbefolkningen i de argentinska Anderna som 
unikt effektiva på att metabolisera arsenik. Allteftersom generationerna fortskred har de 
individer som varit bättre på att eliminera arsenik från sina kroppar haft en större chans att 
överleva och fortplanta sig, tills idag när de flesta som bor i området metaboliserar arsenik 
effektivt. Förmågan att metabolisera arsenik mer eller mindre effektivt bestäms delvis av 
genetiken. Ökningen, efter många generationer, av genetiska variationer som bestämmer 
egenskaper som är fördelaktiga kallas “positiv selektion”.  
Kvinnorna ur ursprungsbefolkningen i de argentinska Anderna har anpassat sig till arsenik 
genom att metabolisera det mer effektivt. Men har den här anpassningen skett även i andra 
delar av Anderna? För att besvara den frågan bjöd vi in kvinnor från ursprungsbefolkningen 
kring Poopósjön i de bolivianska Anderna att delta i vår studie om exponering för arsenik, 
toxicitet och anpassning. 
Först studerade vi hur pass exponerade de bolivianska kvinnorna var för arsenik och hur väl de 
kunde metabolisera arsenik. För att göra detta mätte vi olika restprodukter (metaboliter) från 
arsenikomvandling i kvinnornas urin. Vi såg att kvinnorna runt Poopósjön exponerades för 
arsenik via dricksvattnet och överlag metaboliserade arsenik effektivt. Har arseniken trots detta 
toxiska effekter?  
I den andra och tredje studien utvärderade vi arsenikens toxicitet hos dessa kvinnor. Eftersom 
studieområdet inkluderar avlägsna byar med begränsad tillgång till sjukvård, hade vi inte 
information om hur många kvinnor som utvecklade vissa sjukdomar. Istället mätte vi 
indikatorer på sjukdomar och toxicitet på molekylär nivå i urin och blod, så kallade 
biomarkörer. I den andra studien hade kvinnor som var mer exponerade för arsenik och 
metaboliserade arsenik mindre effektivt en högre koncentration av biomarkörer relaterade till 
tidiga tecken på cancer och oxidativa skador på DNA och lipider. I den tredje studien upptäckte 
vi att koncentrationen av vissa proteiner i urin relaterade till processer som leder till cancer var 
olika beroende på hur exponerade kvinnorna var för arsenik. 
I avhandlingens fjärde och sista studie fann vi att genetiska variationer associerade med en mer 
effektiv arsenikmetabolism var mycket vanliga hos dessa bolivianska ursprungsgrupper. Vi 
fann även tecken på positiv selektion i deras arvsmassa relaterade till arsenikmetabolism. 
Sammanfattningsvis visar denna avhandling att kvinnor ur ursprungsbefolkningen boende i de 
bolivianska Anderna var exponerade för arsenik och överlag hade en effektiv 
arsenikmetabolism tack vare genetisk adaption efter många generationer. Det finns dock 
indikationer på att arsenik är giftigt hos dessa populationer, så fler insatser behövs för att 
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Inorganic arsenic is one of the most potent carcinogens found in the environment. It is estimated 
that more than 140 million people around the world are exposed to inorganic arsenic via 
drinking water. Arsenic is naturally released into drinking water sources due to leaching 
processes. In the Andean plateau in South America, arsenic is easily released from the 
arsenic-rich volcanic bedrock. This creates a scenario in which indigenous populations have 
been, and are still today, exposed chronically over multiple generations to elevated arsenic 
concentrations via their drinking water.  
In 1995, a group of indigenous Andean women living in the remote village of San Antonio de 
los Cobres in northwestern Argentina was described as having a distinctively efficient arsenic 
metabolism, a protective factor against arsenic toxicity (Vahter et al., 1995). This Andean 
region is characterized by very high arsenic concentrations in their drinking water (up to 
200 µg/L) and in the nearby river (800 µg/L). Later studies focusing on this population revealed 
important genetic insights about the metabolism of arsenic. Variants in AS3MT, the gene coding 
for the arsenite methyltransferase, were associated with a more efficient arsenic methylation. 
These Andean women from San Antonio de los Cobres had a very high frequency of the 
protective AS3MT genetic variants compared to other populations worldwide (Engström et al., 
2011; Schläwicke Engström et al., 2009; Schlebusch et al., 2015). This led to the first 
description of human adaptation to arsenic, supported by traits of genomic positive selection 
around AS3MT in these women (Schlebusch et al., 2015). This discovery directed us towards 
the current question approached in this thesis: has this adaptation to tolerate arsenic and 
metabolize it more efficiently occurred elsewhere?  
Following the Andean mountain range, the Bolivian plateau has similar geological settings as 
in Argentina. Villages around Lake Poopó in Bolivia, situated in the central region of the 
highlands, are known to contain elevated arsenic concentrations in drinking water (Ormachea 
Muñoz et al., 2013; Ramos Ramos et al., 2012). Despite this, the extent to which these 
inhabitants around Lake Poopó were exposed to arsenic was not known. Therefore, one of the 
aims of this thesis was to characterize human exposure to environmental arsenic and the arsenic 
metabolism efficiency of indigenous Bolivians living around Lake Poopó. 
Limited data exist on whether individuals with an efficient arsenic metabolism are less likely 
to develop arsenic-related health outcomes. The inherent difficulty to obtain accurate clinical 
data in these remote villages in the Andes stresses the need to identify and evaluate other 
biomarkers of toxicity in relation to arsenic. Therefore, this thesis work also focused on 
exploring the effects of arsenic in the Bolivian communities by using a combination of 
traditional and potential novel biomarkers of toxicity. 
The work included in this thesis meets at the intersection of molecular epidemiology and 
population genetics. It hopes to help unravel how indigenous communities in the Andes have 
adapted to living in arsenic-rich environments and what consequences this long-lasting 






2.1.1 Forms, sources, and exposures 
While arsenic is known in popular culture as a poison used to discreetly commit murders, 
humans are exposed unintentionally to this metalloid because of its ubiquitous presence in the 
environment. Arsenic forms are categorized as inorganic and organic (Figure 1). The inorganic 
forms include arsenite (AsIII) and arsenate (AsV), which are the major forms in water. Organic 
forms are found primarily in food items as arsenosugars, arsenobetaine, arsenocholine, and 
arsenolipids; or are the products of the metabolism of inorganic arsenic, mostly as 
monomethylarsonic acid (MMA) and dimethylarsinic acid (DMA). Even inorganic arsenic and 
DMA are found in food. 
 
Arsenic is hardly ever found in nature in its elemental state. It is, however, a component of 
more than 200 minerals in its inorganic forms, often in combination with sulfur. The most 
common arsenic-containing minerals are realgar (or arsenic disulfide), arsenopyrite, and 
orpiment (or arsenic trisulfide). The erosion of these naturally occurring minerals is the main 
contributor to arsenic leaching into surface and groundwater. Anthropogenic activities, such as 
mining and the use of arsenic-containing fertilizers, also release arsenic into the environment. 
For humans, drinking water is the main source of exposure for inorganic arsenic. In 1993, a 
guideline value of 10 µg/L of arsenic in drinking water was established (WHO, 2017). In the 
South American continent, this guideline value was incorporated in national regulations of 
several countries, including Bolivia, whilst other countries such as Uruguay, Peru, and 
Venezuela maintained the previous higher limit of 50 µg/L (as reviewed in Bundschuh et al., 
2012). 
Figure 1. Summary of arsenic forms. The forms including a methyl group (-CH3) are organic forms. 
 
4 
Food is also a considerable source of arsenic. In fact, rice is an important exposure source of 
inorganic arsenic after drinking water, and it can also contain DMA (Kumarathilaka et al., 
2019; Zhao et al., 2013). In certain types of seafood, such as crabs and mollusks, MMA and 
DMA have also been detected (Borak and Hosgood, 2007). Seaweed has also been reported to 
contain high concentrations of arsenosugars and inorganic arsenic (Molin et al., 2015; Taylor 
et al., 2017). Additionally, arsenic analogues of betaine and choline (arsenobetaine and 
arsenocholine), and various arsenosugars and arsenolipids are found mainly in marine animals, 
but no toxic effects of these organic forms have been clearly associated with human 
consumption. However, despite the generally accepted idea that organic arsenic forms are not 
toxic, the scarce supporting data highlight the need for further assessment (Bornhorst et al., 
2020; Molin et al., 2015). 
2.1.1.1 Exposure in Bolivia 
Elevated arsenic concentrations in drinking water are widespread in Latin America (Bundschuh 
et al., 2012; Khan et al., 2020). In the Andes, the longest mountain range running north to south 
through the South American continent, arsenic is released mainly into the environment due to 
leaching processes of arsenic-rich volcanic rocks. The Andean plateau refers to the region with 
the widest surface of highland and covers southern Peru, western Bolivia, and northern areas 
of Chile and Argentina (Rupert and Hochachka, 2001). In some of these Andean countries, 
such as Argentina and Chile, human exposure to inorganic arsenic has been described in detail 
(Concha et al., 1998a; Francisca and Carro Pérez, 2009; Nicolli et al., 2010; Smith et al., 2018; 
Vahter et al., 1995). However, to date little is known about human exposure to arsenic in 
Bolivia. 
A literature review on the problem of arsenic in Latin America highlighted two areas of concern 
in Bolivia (Bundschuh et al., 2012): the Pilcomayo River basin, in the western Andean region 
of Bolivia, due to its contamination from mining activities in the area; and the axis of the 
Titicaca-Desaguadero-Poopó-Salt basin, mostly being affected by naturally occurring arsenic 
and to some extent by mining activities. The Titicaca-Desaguadero-Poopó-Salt basin consists 
of the northern Lake Titicaca draining through the Desaguadero River into Lake Poopó. In the 
areas around Lake Poopó, arsenic concentrations in ground and surface water have been 
characterized in order to understand the geochemistry of the metalloid in this region (Garcia 
Moreno, 2006; Ormachea Muñoz et al., 2016, 2013; Ramos Ramos et al., 2012; Stassen et al., 
2012; Van Den Bergh et al., 2010). In villages around Lake Poopó, up to 250 µg/L of arsenic 
have been described in water (Ormachea Muñoz et al., 2013; Ramos Ramos et al., 2012). 
To properly estimate the health impacts of arsenic on humans, detailed exposure assessments 
must be carried out. In Bolivia, several studies have explored human exposure to arsenic. 
Archer et al. (2005) reported that total arsenic concentrations in urine ranged 11–891 µg/L in 
villages in the upstream area of Pilcomayo River with low levels of arsenic in drinking water. 
This study, however, only assessed total arsenic concentrations and therefore, the possibility of 
exposure to e.g., arsenobetaine or other less-toxic arsenic forms cannot be discarded. Moreover, 
Smolders et al. (2006) noted that people living downstream of Pilcomayo River (n = 83) were 
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exposed to inorganic arsenic based on arsenic concentrations in hair samples. New data on 
human exposure to inorganic arsenic in Bolivia are steadily emerging, including several studies 
exploring arsenic exposure in the mining city of Oruro (Barbieri et al., 2016; Goix et al., 2016, 
2011; Pavilonis et al., 2017). However, little is still known about human exposure to inorganic 
arsenic in Bolivia. Therefore, a comprehensive analysis is necessary to shed light on arsenic 
exposure levels and to help estimate the magnitude of the problem. Such studies are also 
essential to carry out follow-up analyses on efficient arsenic detoxification, as in nearby study 
populations in Argentina (Vahter et al., 1995).  
2.1.2 Toxicokinetics in humans 
2.1.2.1 Absorption and distribution 
In the general population, humans are exposed to arsenic mainly via ingestion; generally, only 
minute amounts of arsenic are inhaled. After an ingested dose of inorganic arsenic, 80-90% of 
the dose is absorbed in the gastrointestinal tract (Vahter and Norin, 1980). Both AsIII and AsV 
are taken up in the gastrointestinal tract, and AsV is then reduced in the blood to its trivalent 
form (Vahter and Envall, 1983). Once reduced, AsIII is transported to the liver, where it is 
metabolized (Figure 2). 
 
Figure 2. Kinetics of inorganic arsenic in humans after exposure via drinking water and simplified 
methylation pathway in the hepatocyte. Note: Others* refers to arsenic metabolites that are excreted in
urine but are not the product of inorganic arsenic metabolism, e.g., arsenobetaine or arsenocholine.
Abbreviations: As, arsenic; AS3MT, arsenite methyltransferase; DMA, dimethylarsinic acid; iAs, 
















































Arsenic crosses biological membranes by different mechanisms. To achieve this, AsV is known 
to compete with inorganic phosphate for sodium-phosphate transporters during cellular uptake 
(Villa-Bellosta and Sorribas, 2008). In the case of trivalent forms, several membrane transport 
proteins are involved including the families of aquaporins and multidrug resistance proteins (as 
reviewed in Garbinski et al., 2019). In enterocytes, hepatocytes, and epithelial cells located in 
the intestine, liver, and kidneys respectively, several types of these proteins regulate the traffic 
of trivalent arsenic forms through membranes (as reviewed in Roggenbeck et al., 2016). In 
addition, arsenic is known to cross the placenta (Concha et al., 1998b), but more research is 
still required to understand this transport at a molecular level. 
2.1.2.2 Metabolism 
The metabolism of inorganic arsenic in humans takes place primarily in the liver. Arsenic is 
metabolized by a series of reduction and methylation reactions, resulting in the production of 
MMA and DMA (Vahter, 2000). AS3MT is the main arsenic methylating enzyme, which uses 
S-adenosyl methionine (SAM) from the one-carbon metabolism cycle as a methyl donor 
(Koller et al., 2020; Lin et al., 2002; Marafante and Vahter, 1984). 
Not all absorbed inorganic arsenic is metabolically transformed in humans: non-methylated 
inorganic arsenic is excreted in urine along with the methylated products, MMA and DMA. 
Humans produce mainly MMA and DMA after the ingestion of inorganic arsenic. However, 
an oxidized trimethylated species (trimethylarsine oxide, TMAO) has also been detected in 
urine of humans exposed to DMA or arsenosugars in a controlled manner (Francesconi et al., 
2002; Marafante et al., 1987). The reason why humans do not generally produce TMAO is 
probably due to the fast excretion of DMA resulting in low concentrations of DMA in 
hepatocytes (see Section 2.1.2.3 for more details). Interestingly, the methylation of MMA to 
DMA may also be inhibited by inorganic arsenic, limiting the amount of DMA in the liver 
(Lindberg et al., 2008a; Marafante et al., 1987). Other thioarsenic metabolites containing sulfur 
have been identified in human urine after the ingestion of arsenosugars (Francesconi et al., 
2002; Raml et al., 2005). While thio-DMA was initially thought to be an exclusive metabolite 
of arsenosugars, it was recently identified in urine from Bangladeshi women exposed mainly 
to inorganic arsenic (Raml et al., 2007). 
Although arsenic methylation seems to be present among most species except, for example, 
insects and angiosperms (Palmgren et al., 2017), there are major differences in arsenic 
metabolism and kinetics among mammalian species (Vahter, 1999). Thus, human studies are 
required to understand human arsenic metabolism. 
2.1.2.3 Excretion and biomarkers of exposure 
The half-life of inorganic arsenic in the human body is around 2-3 days (Buchet et al., 1981), 
and urine is the main route of excretion. Arsenic is also excreted in feces, sweat, nails, and hair 
but the extent of these routes is insignificant compared to that of urine (ATSDR, 2007). The 
accumulation of arsenic in hair and nails is due to the metalloid’s affinity for sulfhydryl groups, 
which are abundant in the keratin of these tissues. Of all arsenic metabolites, DMA is most 
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rapidly cleared from the liver and excreted via urine (Gamble et al., 2007; Marafante et al., 
1987). On average for humans, the arsenic metabolite fractions in urine are 10–30% 
unmethylated inorganic arsenic (iAs, defined as the sum of AsIII and AsV), 10–20% MMA, and 
60–70% DMA (Vahter, 1999). This indicates a marked variation among individuals regarding 
their capacity to methylate arsenic. In addition, rice consumption can also lead to an increased 
fraction of DMA in urine (Cascio et al., 2011; Meharg et al., 2014). 
Arsenic concentration in urine is the most commonly used biomarker of exposure to assess 
recent intake (Concha et al., 2006; Marchiset-Ferlay et al., 2012). To evaluate exposure to 
inorganic arsenic over a longer period of time, arsenic can be measured in nails and hair, but 
caution must be taken in case of external contamination (Concha et al., 2006; Marchiset-Ferlay 
et al., 2012; Signes-Pastor et al., 2021). Arsenic in blood is not often used as a biomarker of 
exposure since it is quickly cleared from this matrix (ATSDR, 2007). However, in populations 
that are exposed chronically with a constant intake of inorganic arsenic, concentrations in urine 
and blood are known to correlate, and blood arsenic then serves as a valid biomarker of 
exposure (Concha et al., 1998a; Hall et al., 2006; Takayama et al., 2021). Distinguishing the 
different arsenic forms in blood has inherent methodological limitations as well, which 
discourages its use as a first-choice exposure biomarker. However, advances are being made 
in this field (Matoušek et al., 2017). 
The prevailing method to determine total arsenic concentrations in urine is inductively coupled 
plasma-mass spectrometry (ICP-MS) (Chen et al., 2014; Francesconi and Kuehnelt, 2004). 
Regarding inorganic arsenic exposure assessment, it is critical to measure arsenic metabolites 
together (for instance by hydride generation) or individually (separating them with 
high-performance liquid chromatography), instead of assessing only total arsenic 
concentrations. The reason is that total arsenic also includes other organic forms, such as 
arsenobetaine, which do not generally contribute to arsenic toxicity. Further, by speciating the 
different arsenic metabolites, one may evaluate how efficient an individual is at metabolizing 
arsenic. 
2.1.3 Toxicity in humans 
2.1.3.1 Acute toxicity 
Arsenic has been used historically as the poison of choice. In fact, during the Middle Ages it 
was the most common homicide method. Arsenic poisoning went easily undiscovered because 
inorganic arsenic is odorless and tasteless, and the acute poisoning symptoms − nausea, 
vomiting, diarrhea, and abdominal pain − are common to other diseases. 
Despite its toxicity, or probably due to it, arsenic has also been used therapeutically for more 
than 2,400 years (Antman, 2001). For instance, during the 18th century, Fowler’s solution, a 
potassium bicarbonate-based solution of arsenic trioxide, was used against malaria, syphilis, 
asthma, eczema, and psoriasis (Rohe, 1896; Scheindlin, 2005 from Hughes, 2011). In 1910, 
the magic bullet Salvarsan, discovered by Paul Ehrlich, was the main treatment against syphilis 
and trypanosomiasis until the discovery of penicillin (Antman, 2001). 
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Still today, arsenic has a place in modern medicine. Arsenic trioxide is employed as a treatment 
for specific types of acute promyelocytic leukemia, a cancer form characterized by an 
accumulation of promyelocytes. Already in 1878, Fowler’s solution was reported to reduce 
white blood cell counts (Antman, 2001). In 2000, the U.S. Food and Drug Administration 
approved arsenic trioxide as a treatment against acute promyelocytic leukemia (Antman, 2001). 
Cases of this leukemia are characterized by a chromosomal translocation between 
chromosomes 15 and 17 that results in the fusion protein PML-RAR-α. Currently there is 
evidence that arsenic trioxide degrades this fusion protein, which could be related to the drug’s 
selectivity in the treatment of acute promyelocytic leukemia cases (Chen et al., 1997, 2011; 
Shao et al., 1998). 
2.1.3.2 Chronic toxicity 
Although a guideline value of 10 µg/L of inorganic arsenic in drinking water is proposed, 
higher concentrations are estimated to affect at least 140 million people around the world 
(WHO, 2017). Given the large number of individuals exposed, inorganic arsenic poses a 
serious concern from a public health perspective. 
Enough evidence exists for arsenic to be classified as a human carcinogen of group 1, according 
to the International Agency for Research on Cancer (IARC, 2012). Exposure to inorganic 
arsenic via ingestion is associated with multiple types of cancer, such as lung, bladder, and 
skin; and potentially with cancers of the kidney, liver, and prostate (IARC, 2012). Early signs 
of chronic arsenic toxicity include changes in skin pigmentation, particularly in palms and 
soles, followed by hyperkeratosis, a thickening of the skin in the form of patches (Guha 
Mazumder, 2003). These skin lesions can indicate a susceptibility to develop cancer in relation 
to arsenic exposure (Hsu et al., 2013). 
Chronic exposure to inorganic arsenic via drinking water is also associated with several 
non-cancer outcomes. Multiple epidemiological studies show an association with 
cardiovascular and respiratory diseases, diabetes, immunotoxicity, and multiple types of child 
developmental adverse outcomes (Ahmed et al., 2014; Gardner et al., 2013; Hamadani et al., 
2011; Huang et al., 2011; Raqib et al., 2017; Saha et al., 2012; Wang et al., 2007).  
In utero exposure to arsenic has been associated with negative health outcomes at birth and 
later on in life. It has been associated with slightly lower birth weight, respiratory diseases, and 
overall increased risk of child mortality (Smith et al., 2013, 2012; Vahter, 2009). There is 
growing evidence that it is also related to an impaired immune function (Ahmed et al., 2014; 
Raqib et al., 2017). Furthermore, early-life exposure to arsenic has also been associated with a 
markedly increased risk of respiratory diseases, cancer and mortality in adulthood (Dauphiné 
et al., 2011; Roh et al., 2018). 
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2.1.3.3 Mechanism of toxicity 
The potency of arsenic resides in its ability to interfere with a plethora of cellular processes 
through different molecular mechanisms of action. In addition, the oxidation state and the form 
of arsenic play a fundamental role in its toxicity. 
The pentavalent form, AsV, is capable of mimicking phosphorus since both have similar 
physicochemical properties. In this way, AsV disrupts the mitochondrial respiratory chain by 
uncoupling ATP formation in a process termed “arsenolysis” (Doudoroff et al., 1947). This has 
been shown in cellular experiments where AsV depletes the formation of ATP in erythrocytes 
from rabbits (Delnomdedieu et al., 1994) and humans (Winski and Carter, 1998). However, the 
internal dose in the human body to AsV is relatively low since it is quickly reduced to AsIII. 
Trivalent forms including AsIII, MMAIII, and DMAIII have a high affinity to react with thiol 
groups, for example those in sulfhydryl groups present in proteins (Hughes, 2002). Because of 
this, the trivalent forms are generally more toxic than their pentavalent counterparts are. Several 
in vitro studies suggest that MMAIII is the most toxic form (Hirano et al., 2004; Mass et al., 
2001; Petrick et al., 2000; Wang et al., 2015). The increased toxicity of MMA compared to that 
of DMA is probably related to the fact that DMA is more readily excreted (Marafante et al., 
1987). 
The affinity of arsenic to react with sulfhydryl groups in proteins is associated with oxidative 
stress induction, abnormal cell proliferation, protein misfolding and aggregate formation, 
apoptosis induction, impairment of DNA repair mechanisms, epigenetic alterations, 
mitochondrial dysfunction, and modification of telomeres (Bhattacharjee et al., 2013; Chen et 
al., 2019; Hubaux et al., 2013; Hughes, 2002; Jacobson et al., 2012; Khairul et al., 2017). While 
arsenic is a known carcinogen, it has not been demonstrated to react directly with DNA 
(as reviewed in Cohen et al., 2016; Mass et al., 2001). 
2.1.4 Metabolism efficiency as a susceptibility factor 
There is a marked inter-individual variation regarding the efficiency to methylate arsenic 
(Vahter, 1999). More efficient arsenic metabolizers are individuals who present higher 
fractions of DMA in urine, and lower fractions of MMA. Not only are they better at methylating 
the element, but they also have higher excretion rates and less retention since DMA is more 
readily excreted (Gamble et al., 2007; Vahter, 1999). An indigenous population in the Andes 
living in the Argentinean village of San Antonio de los Cobres (SAC) had distinctively low 
MMA and high DMA fractions in urine indicating an efficient arsenic methylation (Vahter et 
al., 1995). 
The efficiency to metabolize arsenic plays a central role in arsenic toxicity. This is mostly 
because the metabolism of arsenic acts both as a bioactivation and detoxification process: 
methylating iAs once converts it into a more toxic form (MMA), while methylating it twice 
(DMA) promotes its excretion. In fact, epidemiological studies have shown that a higher 
fraction of MMA in urine is associated with health effects related to arsenic such as arsenic-
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induced skin lesions, cancer and cardiovascular effects (Ahsan et al., 2007; Antonelli et al., 
2014; Chen et al., 2003; Lindberg et al., 2008b; Pierce et al., 2013; Steinmaus et al., 2006; 
Tseng et al., 2005). This supports the idea that a less efficient arsenic metabolism is a 
susceptibility factor for arsenic toxicity. Throughout this thesis, higher fractions of MMAV in 
urine were considered an indicator of arsenic-related toxic outcomes, assuming it reflects a 
higher internal dose of MMAIII. However, lower MMA and higher DMA fractions in urine 
have also been linked to an increased incidence of diabetes, although further research is still 
needed to understand their causal role (Kuo et al., 2015; Mendez et al., 2016; Nizam et al., 
2013). 
2.1.5 Factors influencing arsenic metabolism 
The variation in urinary arsenic metabolite patterns among individuals is known to be governed 
by several factors. Sex, age, smoking, nutritional status, the dose of inorganic arsenic itself, and 
genetics (see Section 2.1.6 for more details) modulate how well humans cope with arsenic in 
their bodies. 
Women have a greater arsenic methylation capacity in comparison to men (Lindberg et al., 
2008a; Tseng, 2009; Vahter et al., 2007). The underlying cause is thought to be estrogens. 
These primary female sex hormones enhance the endogenous synthesis of choline and betaine, 
the latter being involved in the re-methylation of homocysteine to methionine, in parallel to the 
folate-vitamin B12 cycle (Vahter, 2009). Increased methionine results in higher concentrations 
of SAM, the methyl donor within the one-carbon metabolism that is also used to methylate 
arsenic. The increased arsenic metabolism capacity of women is further enhanced during 
pregnancy (Gardner et al., 2011), supporting the contribution of estrogens to arsenic 
metabolism. 
Children are also known to be more efficient at methylating arsenic than adults (Skröder 
Löveborn et al., 2016; Sun et al., 2007; Tseng, 2009). This is thought mainly to be due to the 
upregulation of the one-carbon metabolism for the production of SAM in children while they 
are growing (Hall et al., 2009), and/or due to children being exposed to fewer inhibiting factors, 
such as smoking. 
Regarding modifiable factors, smoking is associated with an impaired one-carbon metabolism. 
Smokers have lower levels of the one-carbon cofactors folate, vitamin B6 and B12, and higher 
levels of homocysteine (O’Callaghan et al., 2002). This can lead to lower concentrations of 
SAM and a reduced arsenic methylation capacity. In fact, smokers present higher MMA 
fractions than non-smokers (Hopenhayn-Rich et al., 1996; Lindberg et al., 2010). 
Multiple studies have also assessed how the nutritional status of humans affects their capacity 
to methylate arsenic. Primarily, diets deficient in protein, which means the methyl group intake 
is reduced, may result in a less efficient arsenic methylation (Kordas et al., 2016; Steinmaus et 




Elevated arsenic exposure levels can inhibit the methylation of inorganic arsenic to MMA and 
DMA. Epidemiological studies found that higher arsenic concentrations in urine were 
associated with lower DMA fractions, i.e., those individuals had an impaired arsenic 
methylation (Hopenhayn-Rich et al., 1996; Olmos et al., 2015; Skröder Löveborn et al., 2016; 
Sun et al., 2007). This idea is supported by in vitro studies showing that arsenic metabolism 
enzymes were inhibited by inorganic arsenic (Buchet and Lauwerys, 1988; Styblo et al., 1996). 
2.1.6 Genes involved in arsenic metabolism 
2.1.6.1 Candidate-gene approach 
Little more than a decade ago, only few studies approached the idea that genetics could also 
contribute to the variability of arsenic metabolism. Since then, the knowledge pool has grown 
enormously, and today there is clear evidence that variations in genes related to arsenic 
metabolism affect the body’s capacity to cope with inorganic arsenic. Not only are these genetic 
variants associated with arsenic metabolism efficiency, but some have also been shown to be 
associated with arsenic-related toxic outcomes. 
The key enzyme in the methylation of inorganic arsenic is AS3MT (first annotated as cyt19), 
an arsenite methyltransferase capable of methylating inorganic arsenic, MMA, and DMA 
(Thomas et al., 2007). The genetic structure of AS3MT is composed of 11 exons over 
approximately 32,000 base pairs and it is located on chromosome 10 (10q24.32). The role of 
AS3MT in arsenic metabolism has been demonstrated in both in vitro and in vivo studies. 
Human urothelial cells that did not express AS3MT were not capable of methylating arsenic 
(Drobná et al., 2005), and As3mt knockout mice presented an impaired arsenic methylation 
capacity (Drobná et al., 2009). Regarding arsenic methylation variability within humans, 
variants in AS3MT have been shown to predict arsenic metabolite fractions in populations 
throughout the world (Antonelli et al., 2014; Engström et al., 2007; Ghosh et al., 2008; 
Hernández and Marcos, 2008). Despite this, it is still unclear which variants of AS3MT are 
causative. In a review by Antonelli et al. (2014), 360 articles published before 2013 found a 
total of 15 AS3MT variants associated with arsenic methylation. However, only three of these 
(rs3740390, rs11191439, and rs11191453) were influential across populations. Nevertheless, 
this heterogeneous number of variants associated with arsenic methylation throughout studies 
could be explained partly by the strong linkage disequilibrium that exists around AS3MT 
(Engström et al., 2011; Gomez-Rubio et al., 2010; Schläwicke Engström et al., 2009). 
Most of the AS3MT polymorphisms associated with arsenic methylation are non-coding. This 
indicates that these genetic variants are likely to contribute to arsenic methylation differences 
by modulating the gene expression of AS3MT. The adrenal gland, spleen, brain, and liver are 
the organs with the highest expression of AS3MT, but its function in other organs apart from 
the liver is still unknown. Genetic variants associated with a more efficient arsenic methylation 
in the Andean population from SAC have been correlated with a reduced gene expression of 
AS3MT in peripheral blood (Engström et al., 2011, 2013). These seemingly counter-intuitive 
results may be explained by gene expression being measured in blood instead of in liver tissues, 
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the main methylating organ. Recently, a study based on tissue-specific gene expression data 
from the GTEx database (Genotype-Tissue Expression project) found that AS3MT variants 
associated with a less efficient arsenic methylation also had a reduced AS3MT expression in 
several tissues, but not in liver (Chernoff et al., 2020). 
A longer list of genes involved has additionally been in the spotlight (as reviewed in Antonelli 
et al., 2014; Ghosh et al., 2008; Hernández and Marcos, 2008); for instance, enzymes in charge 
of the reduction of arsenic. One example is the MMAV reductase, in humans encoded by the 
gene GSTO1, which is a glutathione S-transferase (Zakharyan et al., 2001). Glutathione S-
transferases are a superfamily of enzymes that are crucial during metabolism because they 
catalyze the conjugation to reduced glutathione. Another candidate as a catalyzer for the 
reduction of pentavalent arsenic is the purine nucleoside phosphorylase enzyme, encoded by 
PNP (Németi et al., 2010). Variations in PNP have been associated with arsenic-related skin 
lesions (De Chaudhuri et al., 2008). Genetic variants in other methyltransferases, such as 
N6AMT1, have also been associated with arsenic methylation (Chen et al., 2017; de la Rosa et 
al., 2017; Harari et al., 2013). Arsenic methylation capacity is also affected by genetic variants 
related to the one-carbon metabolism enzymes (Hernández and Marcos, 2008; Schläwicke 
Engström et al., 2009). Lastly, a group of genes that could influence the toxicity of arsenic are 
those involved in DNA repair mechanisms that respond to the genetic insults induced by 
arsenic-related oxidative stress (Ghosh et al., 2008). 
2.1.6.2 Genome-wide approach 
With the development of technologies that enable researchers to produce and handle large 
amounts of data, the way we assess how genetics could influence arsenic metabolism has 
changed. It is now possible to evaluate thousands and millions of genetic polymorphisms at a 
time. This shift allows us to study the effect of genetics on arsenic metabolism and on arsenic-
related toxic outcomes at a genome-wide level. The use of genome-wide association studies, 
also known by their abbreviation GWAS, introduces a new conceptual framework that is 
hypothesis-free. A summary of studies that have evaluated the genetic contribution of arsenic 
metabolism in humans using a genome-wide approach is included in Table 1. The main 
arsenic-related outcome assessed in these genome-wide studies has been skin lesions (Argos et 
al., 2018; Kibriya et al., 2017; Pierce et al., 2013, 2012). 
Signals in AS3MT are the common denominator throughout these studies (Balakrishnan et al., 
2017; Gao et al., 2015b; Pierce et al., 2012; Schlebusch et al., 2015, 2013). Other signals have 
also been detected in different regions of the genome apart from AS3MT (Gribble et al., 2015; 
Pierce et al., 2019; Schlebusch et al., 2015; Tellez-Plaza et al., 2013). Nevertheless, a functional 
characterization is still pending to validate the contribution and relation of these genes with 





Table 1. Genome-wide association studies for arsenic metabolism efficiency or toxicity outcomes in humans. 
 Abbreviations: AS3MT, arsenite methyltransferase; BEST, Bangladesh vitamin E and selenium trial; CNV, copy number variation; DMA, dimethylarsinic acid; FTCD, 
formiminotransferase cyclodeaminase; GWAS, genome-wide association study; HEALS, health effects of arsenic longitudinal study; iAs, inorganic arsenic; MMA, 
monomethylarsonic acid; PCA, principal component analysis; QTL, quantitative trait locus; SAC, San Antonio de los Cobres (Argentina); SNP, single nucleotide polymorphism. 
Country Study 
population 
Genetic data Participants 
included 
n Main results Reference 
Bangladesh HEALS 
BEST 
Illumina HumanCytoSNP-12 v2.1 
~300,000 SNPs 
Adults 1,313 - GWAS signal for AS3MT for both MMA and DMA. 
- SNP rs9527 (from AS3MT) associated with skin lesions in a follow up with 
case-control subjects. 




Illumina HumanCytoSNP-12 v2.1 
~300,000 SNPs 
Adults 2,053 - Heritability estimation: 16% of DMA fraction was explained by the studied 
SNPs, when including distant relatives. 
- Strongest signal around AS3MT. 
Gao et al., 
2015 
Bangladesh HEALS Illumina HumanCytoSNP-12 v2.1 
~300,000 SNPs and 4,829 CNVs 
Adults (no 
skin lesions at 
enrollment) 
2,171 - Higher risk of developing arsenic-induced skin lesions over time associated 
with genomic deletions in several genes (OR5J2, GOLGA6L7P, APBA2, 
GALNTL5, VN1R31P, PHKG1P2, SGCZ, and ZNF658). 
Kibriya et al., 
2017 
Bangladesh  HEALS 
BEST 
Illumina HumanCytoSNP-12 v2.1 
~300,000 SNPs 
Adults 5,354 - Gene-environment interaction study using gene expression and DNA 
methylation data. Suggestive signal on chromosome 1 for SNP interaction with 
arsenic-induced skin lesions. 




Illumina exome array v1.1 
~240,000 SNPs 
Adults 1,660 / 
4,873 
- Coding SNP in FTCD associated with all inorganic arsenic metabolite fractions, 
and with increased risk of arsenic-induced skin lesion. 
Pierce et al., 
2019 
USA Strong Heart  
Family Study 




- Heritability estimation: ~ 50% for all inorganic arsenic metabolite fractions. 
- Localized a QTL on chromosome 5 (for %iAs), 10 (for %DMA), and 11 (for 
%iAs and %MMA). 
Tellez-Plaza 
et al., 2013 
USA Strong Heart 
Family Study 
400 microsatellite markers American 
Indian adults 
2,189 - Localized a QTL on chromosome 10 explained partially by AS3MT variants.  
- Localized a QTL on chromosome 5 when assessing it with PCA.  
Gribble et al., 
2015 






2,428 - Variants in chr:10q24 associated with %iAs, %MMA, and %DMA. Balakrishnan 
et al., 2017 
Argentina  SAC and 
villages near 
Salta 
806 microsatellite markers Indigenous 
women in the 
Andes 
346 - Higher frequency of protective AS3MT haplotype in Argentina compared to 
other populations, suggestive of positive selection. 
Schlebusch  
et al., 2013 
Argentina  SAC Illumina Omni5M Chip 
~4.3 million SNPs (GWAS with 
1.3 million SNPs after filtering) 
Indigenous 
women in the 
Andes 
124 - Strong association between AS3MT SNPs and %MMA and %DMA. 
- Weaker association in chromosome 21 with arsenic metabolite fractions. Genes 
in the area: LSS, MCM3AP, and YBEY. 
Schlebusch  




Illumina Omni5Exome Chip  
~4.5 million SNPs (GWAS with 
1.7 million SNPs after filtering) 
Indigenous 




- No clear association for inorganic arsenic metabolites in the GWAS, but an 
association when focused on the protective AS3MT haplotype. 





Heritability has also been evaluated to estimate how much of the arsenic metabolism variation 
is due to genetic variation. Using only close relatives, the heritability for %DMA estimated by 
Gao et al. (2015) was 63%, in line with the estimation of 59% from a family-based study 
(Tellez-Plaza et al., 2013). However, when Gao et al. (2015) included distant relatives, the 
heritability decreased to 16%. The authors suggested that this discrepancy could be due to rare 
variants (not included in the genotyping arrays) contributing to the variability in arsenic 
metabolism capacity. Overall, these studies published until today regarding human arsenic 
metabolism using genome-wide data have been carried out with study groups in Bangladesh, 
the United States, and the Argentinean Andes. This manifests the need to expand this type of 
studies in the future to new populations and regions around the world. 
Discussions regarding arsenic and the human epigenome have also arisen during recent years. 
Multiple efforts have been directed towards grasping how epigenetics markers throughout the 
genome are affected by arsenic exposure and how these modulate arsenic metabolism capacity 
(Bailey et al., 2013; Bozack et al., 2020; Broberg et al., 2014; DiGiovanni et al., 2020; 
Engström et al., 2013; Kaushal et al., 2017; Somnath et al., 2017). 
Interestingly, genome-wide data have also been used for arsenic studies in plant biology. The 
focus of these has been to understand how arsenic accumulates in grains, such as rice, to 
potentially give solutions on how to limit its accumulation in crops in order to avoid exposure 




2.2 POPULATION GENETICS 
Population genetics aims to understand past evolutionary processes (Ewens, 2010). By 
studying allele frequencies within and among populations, this field can potentially reconstruct 
demographic and selective processes that have shaped the gene pool of today’s populations. 
Population genetics concerns the study of population structure and adaptation, among others. 
2.2.1 Population structure of Andean indigenous groups 
Population structure is defined as the departure from random mating in a population. 
For example, people often produce offspring with those nearby. This creates specific genetic 
patterns that correlate with the geographical distribution of those populations (Coop et al., 
2009). In this sense, population structure is vital to assess the history of populations since it 
reflects demographic and migratory movements. It is important to note that population structure 
(or stratification) can affect association studies since it can act as a confounding factor 
(Bauchet, 2008). 
The most widespread indigenous populations in the Andean plateau are the Aymara and the 
Quechua. These two ethnic groups are primarily linguistically defined, and they were the 
predominant languages of the Andean plateau during the arrival of the Spaniards (Sandoval et 
al., 2013). Yet in 1990, in the highlands of Ecuador, Peru, Bolivia, and Argentina, more than 
6 million people spoke Quechua, while almost 2 million inhabitants near Lake Titicaca and 
La Paz spoke Aymara (Rupert and Hochachka, 2001).  
The Uru live in the Andean plateau between present-day Bolivia and Peru, and they have been 
historically isolated from other surrounding communities (de la Barra Saavedra et al., 2011). 
In Peru, the majority of Urus live in the floating islands of Lake Titicaca, while in Bolivia they 
are separated in three independent communities. The Uru-Chipaya live near Lake Coipasa, the 
Uru-Irohito on the banks of Desaguadero River, and the Uru-Murato (or Uru-Poopó) live in 
several villages surrounding Lake Poopó (Sandoval et al., 2013). 
Most research investigating the genetic history of populations in the Andes has included the 
main groups: Aymara and Quechua. The Aymara and Quechua ethnicities are fairly similar 
from a genetic perspective (Batai and Williams, 2014; Lindo et al., 2018). Furthermore, a study 
of mitochondrial DNA data from Bolivian individuals suggested that those populations living 
in the foothills were more closely related to Andean populations than to Amazonian ones 
(Corella et al., 2007). Regarding how the Andes were populated from a broader scope, a 
population structure study revealed that the Peruvian highlands might have been a crucial 
region during the early Paleoindian expansions (Gómez-Carballa et al., 2018). The suggested 
time for when populations diverted between low- and highland is estimated between 9,200 and 
8,200 years ago (Lindo et al., 2018). 
Whereas most Andean population structure research has delved into understanding the main 
ethnic groups, one study stands out focusing on the Uru ethnicity minority. In the work by 
Sandoval et al. (2013), the authors used Y-chromosome and mitochondrial DNA data of 
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388 Uru individuals from Peru and Bolivia compared to the uniparental markers of Aymara, 
Quechua, and Arawak populations to evaluate their genetic relationships. Their results showed 
that the Uru are more closely related to Aymara and Quechua from Lake Titicaca than to the 
Amazonian Arawaks. They also presented that the Uru populations from Peru and Bolivia are 
genetically differentiated. This study focused on uniparental markers and therefore, more 
studies including genome-wide data are needed. 
2.2.2 Human adaptation 
Humans live in countless and ever-changing habitats with a wide range of lifestyles. The fact 
that humans can inhabit such different, and sometimes harsh and seemingly inhospitable, 
geographic environments indicates that our species has a strong ability to adapt. At a genetic 
level, adaptation occurs when individuals from a specific population, over successive 
generations, inherit advantageous traits that increase their fitness and survival under specific 
conditions. Therefore, adaptation refers to traits sculpted by natural selection and is one of the 
driving forces of evolution (Mitton, 2002). 
2.2.2.1 Processes driving adaptation 
While adaptation regards the phenotype granting reproductive advantage, natural selection is 
the process driving and assuring that it is passed on to the coming generations. Therefore, 
adaptation is said to be a product of natural selection. However, selection is not the only driving 
force acting on and modulating the frequencies of alleles in populations. Selection along with 
mutation, gene flow, and genetic drift are four processes that do not work in isolation. These 
processes are mechanisms of evolution that generate changes in the frequencies of alleles 
(Andrews, 2010).  
Mutation, which is a change of the nucleotide sequence, is the only force able to create new 
variation. The frequency of neutral mutations changes randomly in each generation. This is 
known as genetic drift, a process in which populations evolve due to alleles being fixated or 
eliminated by chance (Kimura, 1968). In addition, gene flow refers to the movement of genes 
in and out of a population, for instance due to migratory movements (Andrews, 2010). 
When a phenotypic trait confers survival and reproductive advantages, the underlying genetic 
variant will be inherited with higher probability. Over time, if the advantage is maintained, the 
frequency of this variant will increase in the population. This variant is then under positive 
selection (Harris, 2013). On the contrary, when a variant is deleterious for the individual, the 
frequency of the allele decreases with time until it is eliminated in a process known as negative 
or purifying selection. 
As mentioned above, if an allele is beneficial for the individual’s survival and reproductive 
success, its frequency will increase in that population. At the same time, the variant subject to 
positive selection will drag along other neutral variants near it during recombination, forming 
a “haplotype” that is inherited together in a process termed genetic hitchhiking. As a result, 
these neutral variants nearby will also increase in frequency, and consequently, the variation in 
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the region surrounding the advantageous allele will decrease and haplotype homozygosity will 
increase. This process is referred to as a selective sweep (Harris, 2013). 
Signatures of positive selection in the genome can be detected using different approaches, some 
of which are summarized in the text by Kimura and Ohashi (2013), and can be based on: 
• site frequency within a population (e.g., the Tajima’s D statistic), 
• genetic differentiation between populations (e.g., 2-way and 3-way FST methods), 
• haplotype variation within a population (e.g., Extended Haplotype 
Homozygosity [EHH] tests), or 
• haplotype homozygosity between populations (e.g., the XP-EHH method). 
2.2.2.2 Examples of human adaptation in the Andean plateau 
The Andes Mountains, at an average altitude of 4,000 meters, offer a unique scenario to study 
human adaptation. The longest mountain range in the world is one of the harshest environments 
where humans have thrived. Much attention has been drawn to understanding how humans 
have adapted to the high-altitude hypoxia, especially in areas such as the Tibet and the Andes. 
Genetic signatures of positive selection have been identified in relation to hypoxia at high 
altitude in genes related to cellular oxygen sensing, defense against oxidative stress, modulation 
of pulmonary surfactant production, and cardiac muscle formation (Bigham et al., 2010; 
Jacovas et al., 2018; Lindo et al., 2018; Rupert and Hochachka, 2001; Simonson et al., 2015; 
Valverde et al., 2015). Interestingly, the role of DNA methylation as an epigenetic mechanism 
has also been studied in relation to how humans cope with high altitude. A genome-wide DNA 
methylation study comparing Peruvian populations with different histories of living at high or 
low altitudes identified differentially methylated regions in genes involved in the 
hypoxia-inducible factor pathway, production of red blood cells, and blood pressure 
(Childebayeva et al., 2021). 
The Andean plateau is, however, not only characterized by extreme altitudes. The unique 
geochemistry of the Andes Mountains results in a setting in which indigenous populations have 
been exposed to toxic metals for thousands of years (Núñez et al. 1991). In fact, studies on 
Andean mummies from Chile revealed elevated arsenic concentrations in their hair and internal 
organs, confirming that the inhabitants of these areas have been exposed to arsenic over 
multiple generations (Echeverría et al., 2018; Kakoulli et al., 2014). 
In the Argentinean highlands located at around 3,800 meters above the sea, women from 
San Antonio de los Cobres and surrounding villages were identified as having a unique and 
efficient arsenic metabolism, with low fractions of MMA in urine (Vahter et al., 1995). Nearly 
two decades after this discovery, with the further development of genetic analyses, women 
from the same region were found to have the highest frequency ever described of AS3MT 
polymorphisms associated with a more efficient arsenic metabolism. These women belonging 
mainly to the Kolla ethnic group presented high frequencies of AS3MT alleles linked to a more 
efficient arsenic metabolism (Schlebusch et al., 2013). It was later identified that these women 
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had genetic signatures of positive selection around the AS3MT region (Schlebusch et al., 2015). 
Shortly after, similar results were found in a different subset of men and women from the same 
village using complementary genome-wide selection scans (Eichstaedt et al., 2015). In a less 
comprehensive study, researchers evaluated the frequency of four variants of AS3MT in a 
population from the Atacama Desert in Chile (Apata et al., 2017). The authors concluded that 
this population had a high frequency of alleles associated with a more efficient arsenic 
metabolism; however, no genome-wide selection scans were used to assess traits of positive 
selection in their genome. A more exhaustive study of the Andean region and the inclusion of 




3 RESEARCH AIMS 
The overall aim of this doctoral research project was to clarify the human exposure, toxicity, 
and possible adaptation to arsenic in the Andes Mountains. Specifically, the aims were to: 
• Recruit a new study group of the main indigenous groups (Aymara-Quechua and Uru 
ethnicities) living in the Bolivian Andean highlands to assess their exposure to arsenic 
through drinking water and their arsenic metabolism efficiency (Paper I). 
 
• Evaluate arsenic toxicity and how it may be modified by arsenic metabolism 
efficiency in the Bolivians (Paper II and III). 
 
• Determine whether Bolivian populations from the Andes present signs of positive 
selection related to arsenic (Paper IV). 
 






4 MATERIALS AND METHODS 
This section summarizes and contextualizes the study area and design, as well as the methods 
used throughout this thesis. More technical and detailed descriptions of the methods are 
included in Papers I–IV. 
4.1 STUDY AREA 
The study area comprises numerous villages located around Lake Poopó, 300 km southeast of 
La Paz, Bolivia (Figure 3). Lake Poopó is located on the plateau of the Andes Mountains in 
Bolivia, also referred to as the Bolivian highlands or altiplano, approximately at 3,700 m above 
sea level (17S-20S; 66W-68W). Lake Poopó receives its water mainly from the Desaguadero 
River and through the smaller Lake Uru Uru. Lake Poopó and Lake Uru Uru are shallow saline 
lakes with a maximum depth of 3 and 1 m, respectively, depending on yearly precipitations. 
Due to climate change and misuse of water sources for agricultural activities, Lake Poopó was 
declared in a state of emergency in 2015 (Satgé et al., 2017). The area is characterized by a 
cold semi-arid climate, with pronounced temperature variations within the same day. The rainy 
season in the Bolivian highlands is between December and March. During these months, the 
heavy rain hinders the access to the study villages because of the precarious state of the roads. 
Figure 3. Map of the study area and villages included in the study. Arsenic concentrations in drinking 




Study participants were recruited from 10 villages situated around Lake Poopó, all located 
within the Oruro Department: Bengal Vinto, Crucero Belén, Llapallapani, Pampa Aullagas, 
Poopó, Puñaca, San Felipe de Chaytavi, Santuario de Quillacas, Sevaruyo, and Villañeque 
(Figure 3 and 4). The study area was preselected based on previous literature that identified 
elevated arsenic concentrations in water from villages of this region (Ormachea Muñoz et al., 
2013; Ramos Ramos et al., 2012). Since then, further geochemical characterization of arsenic 
in groundwater has been described (Ormachea Muñoz et al., 2016). 
4.2 STUDY DESIGN AND PARTICIPANTS 
In total, 201 women living in 10 villages located around Lake Poopó were recruited into this 
cross-sectional study. The recruitment of study participants took place between September 
2015 and November 2017 during five trips to conduct field work. However, additional visits 
and meetings were organized at the villages before, during, and after the recruitment period to 
inform about the arsenic problem and to explain the research project to the inhabitants of the 
region. Individuals were invited to participate in the study by the local doctors and nurses, 
during personal visits to the women’s houses, or with the help of announcements on the local 
television. Since the access to these remote villages is limited, the study group resulted from a 
convenience sampling. Mainly women were invited to participate since men in this region often 
work outside the village where they live, impeding the proper characterization of their arsenic 
exposure. In addition, men are more prone to additional exposures such as tobacco and alcohol, 
which are known to affect the capacity to metabolize arsenic. 
The Bolivian study group consists of individuals belonging to the Aymara-Quechua or Uru 
ethnicities. The Aymara and Quechua are the most extended ethnic groups in the Bolivian 
Andes. These two ethnic groups cohabit around Lake Poopó and are relatively similar from a 
genetic perspective (Batai and Williams, 2014; Lindo et al., 2018). Therefore, for the projects 
within this thesis, they were included as a combined Aymara-Quechua subgroup. The Uru 
around Lake Poopó, also known as Uru-Murato, live in Llapallapani, Villañeque, and Puñaca, 
as well as a minority in Poopó. Historically, the Uru have been isolated from their neighboring 
communities (de la Barra Saavedra et al., 2011). This segregation in the past between Uru and 
Aymara-Quechua villages allowed us to assess ethnicity based on where the participants, their 
parents, and grandparents lived. Both ethnic groups depend mainly on agriculture and the trade 
of handcrafts. In the past, the Uru relied on fishing. However, this was not the case during the 
recruitment period because of the lake’s critical state. 
In Paper IV, men belonging to the Uru communities (n = 5) were included in the study of 
genetic selection signals to increase the sample size (following the same sampling protocols as 
for the women) since these analyses are independent of the arsenic exposure and phenotypic 
endpoints. In addition, a subset of women (n = 53) from the Argentinean Andes, earlier 
described as having an efficient arsenic metabolism (Schlebusch et al., 2015), was included in 
Paper IV to evaluate the presence of novel genetic variants in relation to arsenic metabolism. 
These women were recruited in 2008 in San Antonio de los Cobres (SAC) located at 3,800 m 
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above sea level in the northern Argentinean Andes. A summary of the study design and 




Figure 4. Photographs of the study area included in this thesis taken during the field trips. View of 
(A) Pampa Aullagas (October 2016) and (B) Puñaca (October 2017). Health centers at (C) Sevaruyo 
(March 2017) and (D) Llapallapani (October 2017). Examples of systems used to obtain drinking water
at (E) Santuario de Quillacas (October 2016) and (F) San Felipe de Chaytavi (October 2016).






4.3 SAMPLING AND DATA COLLECTION 
Oral and written information about the study was presented to the participants, and after they 
gave their written informed consent, we interviewed them in Spanish. The questionnaire 
included information about their age, parity, time and place of their residency, residency 
location of their parents and grandparents, which water sources they used, general food and 
dietary habits, tobacco and alcohol consumption, coca chewing, and personal and family 
history of diseases. Ethnicity was based on the birthplace of the participants and complemented 
with information on where their parents and grandparents were from. During the interview, 
blood pressure was taken in sitting position, and weight and height were measured. 
Spot urine samples were collected in plastic cups by the participants during the visit. 
Participants received instructions on how to proceed with wet-wipe cleaning and how to collect 
a mid-stream urine sample to avoid bacterial contamination of the urine sample. Directly after, 
we used urine sticks (Combur 7 Test strips, Roche) to obtain a semiquantitative measure of pH, 
and the presence of glucose, ketones, leukocytes, nitrites, proteins, erythrocytes, and 
hemoglobin in urine as indicators of diabetes or urinary tract infection. Urine samples were 
then transferred to 20 mL polyethylene bottles free of trace elements. 
Venous blood samples were taken with BD Vacutainer Eclipse blood collection needles 
(Becton, Dickinson), and collected in EDTA tubes (Vacuette, Greiner Bio) for DNA extraction 
and in Trace Elements NH Sodium Heparin tubes (Vacuette) for the exposure assessment of 
arsenic and other metals. During one of the sampling visits, we did not have Trace Elements 
NH Sodium Heparin tubes, so we collected blood for metal exposure assessment in Lithium 
Heparin tubes (Vacuette) instead. Neither type of tube used for exposure assessment had traces 
of arsenic as confirmed by leach tests. Hemoglobin was measured in venous blood using 
HemoCue201+ (HemoCue) directly after the blood sampling. DNA was extracted from venous 
peripheral blood collected in EDTA tubes with the E.Z.N.A. Blood DNA Mini kit (OMEGA 
Bio-Tek). 
All samples were stored at -18 °C in a portable freezer during the field work trips, generally 
3 days long. Then, they were stored at -20 °C at the Institute of Genetics at Universidad Mayor 
de San Andrés, Bolivia until further shipment with dry ice to Karolinska Institutet, Sweden. 




Figure 5. Study design and participants included in each scientific paper of this thesis. First-degree 
relatives excluded from the subset of Paper I were based on data obtained during the interviews. First-
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4.4 EXPOSURE ASSESSMENT 
All exposure assessment analyses were performed at the Unit of Metals and Health at the 
Institute of Environmental Medicine, Karolinska Institutet, in a laboratory specialized in trace 
element analysis. 
4.4.1 Arsenic in drinking water 
The initial inclusion of villages into the study was based on previous literature describing 
elevated arsenic concentrations in ground and surface water from villages surrounding Lake 
Poopó (Ormachea Muñoz et al., 2013; Ramos Ramos et al., 2012). To illustrate the problem of 
arsenic exposure to the inhabitants, an on-site quick test was used to determine arsenic based 
on a colorimetric assay (MQuant arsenic test, Merck). 
To characterize the exposure to arsenic via drinking water of the study participants, arsenic 
concentrations were measured in several water sources from each village. For that, we collected 
water samples from the main drinking water sources as described by the participants during the 
interviews, including, for example, water from taps, wells, tanks, or rivers. Water coming from 
taps was left to run a couple of minutes before taking the sample to avoid the contamination by 
metals accumulated in the pipes. Water samples were collected in trace-element free 20 mL 
polyethylene bottles and stored and shipped with the other samples (see Section 4.3). 
At Karolinska Institutet, multielement analyses were performed using ICP-MS (Agilent 7700x, 
Agilent Technologies). 
4.4.2 Biomarkers of arsenic exposure 
Total arsenic concentrations in urine, including inorganic and organic arsenic forms, were 
measured by ICP-MS (Agilent 7700x). Urine samples were thawed overnight at 7 °C and 
diluted 1:10 with 1% HNO3 (67% volume/volume). 
The concentrations of different arsenic species that result from the metabolism of inorganic 
arsenic, i.e., iAs as the sum of AsIII and AsV, MMA, and DMA, were measured in urine by 
high-performance liquid chromatography online with hydride generation and ICP-MS (HPLC-
HG-ICP-MS; HPLC Agilent 1110 series; Hamilton column PRP-X100; ICP-MS Agilent 
7500ce). The speciation of arsenic was used to (i) assess the exposure to inorganic arsenic, 
excluding other organic forms of arsenic which are associated with less toxicity such as 
arsenobetaine; and (ii) evaluate how efficiently arsenic is metabolized by calculating the 
relative fractions (percentage) of the metabolite concentrations in urine. The sum of inorganic 
arsenic metabolite concentrations in urine (AsIII + AsV + MMA + DMA; abbreviated as U-As) 
was used as a biomarker of inorganic arsenic exposure. 
Arsenic exposure was also assessed by concentrations of total arsenic in whole blood (B-As). 
These were measured by ICP-MS (Agilent 7900) after diluting the whole blood with an alkali 
solution, sonicating, and centrifuging the sample (Levi et al., 2018). 
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Plastic materials used during the analyses were acid-washed to avoid the contamination by 
trace elements. All quality control materials (commercial reference materials, in-house 
samples, and internal standards) used to assure the accuracy of the results are described in 
Paper I for the urine analyses and in Paper III for the blood analyses. 
4.4.3 Urinary dilution correction 
Collecting 24-h or first morning void urine samples is not feasible during the field trips due to 
practical limitations and low compliance rates. Instead, spot urine samples were collected, 
which serve as a proxy for arsenic concentrations since these measurements have been seen to 
correlate with those in 24-h urine samples, particularly when compensating for variations in 
the urine dilution (Yassine et al., 2011). By doing so, the differences in the concentrations that 
are not due to differences in exposure are corrected. 
Urinary specific gravity and osmolality were measured in the Bolivian study group. Urinary 
osmolality was measured with a digital cryoscopic osmometer (OSMOMAT 030, Gonotec), 
and specific gravity with a digital refractometer (RD172, EUROMEX). In the Bolivian study 
group, U-As adjusted for specific gravity was highly correlated and in agreement with U-As 
adjusted for osmolality (Figure 6).  
 
Urinary arsenic concentrations were adjusted for the mean urinary osmolality of the study 
group to correct for variations in urinary dilution throughout the studies. Although osmolality 
has not been widely used for research purposes, due mostly to the perception of it being costly, 
osmolality is less influenced by urinary glucose and proteins, and socio-demographic and 
medical factors than other correction methods (Parikh et al., 2002; Yeh et al., 2015). In fact, 
recent studies support the use of urinary osmolality as a correction method for the assessment 
of arsenic exposure (Middleton et al., 2019, 2016). On the contrary, creatinine concentrations 
are affected by variations in muscle mass, diet, age, gender, and ethnicity (Barr et al., 2005). 
Figure 6. Scatter plots with loess line of two methods to correct for urinary dilution variation: specific
gravity or osmolality. Among the three women with specific gravity values > 1.035, one had proteins in
urine and the other two had high glucose (the only ones in the study group) based on the urine strips.
Abbreviation: U-As, urinary arsenic as the sum of inorganic arsenic metabolite concentrations. 
rS = 0.94, p < 0.001 rS = 0.99, p < 0.001 
 
28 
Particularly for arsenic, since its metabolism depends on the addition of methyl groups, 
correcting with urinary creatinine values is not recommended (Nermell et al., 2008). 
To explore the toxicity of arsenic in this study group, two other toxicity biomarkers were 
quantified in urine, which make them susceptible to variations in urinary dilution. The effect 
of different urinary dilution correction methods on the associations between arsenic exposure 
and these toxicity biomarkers was explored in Paper II (see Section 4.5.2 for more details). 
4.4.4 Other metals 
The exposure in this study group to other metals and metalloids, including lithium, boron, 
strontium, and cesium, was assessed in drinking water and urine samples by measuring their 
concentrations by ICP-MS (Agilent 7700x, Agilent Technologies). The concentrations of 
lithium and boron in the drinking water samples collected around Lake Poopó were similar to 
those described in SAC, in the Argentinean Andes (Concha et al., 2010), but higher than 
previously reported around Lake Poopó (Ormachea Muñoz et al., 2013; Ramos Ramos et al., 
2012). Additional information about these elements can be found in Paper I. 
4.5 TOXICITY BIOMARKERS 
A biological marker, or biomarker, is a characteristic that can be measured in a sample as an 
indicator of the state of an organism (Muller and Dieterle, 2009). Within environmental health 
research, these are classified as: 
• Biomarker of exposure: how much is an organism exposed to a chemical? 
• Biomarker of susceptibility: does the organism have an impaired capacity to respond 
to the chemical insult compared to others? 
• Biomarker of effect: does the chemical alter the organism to any extent? 
The biomarkers of effect included in Paper II reflect alterations of structures or functions at a 
biochemical level in relation to established mechanisms, such as via the induction of oxidative 
stress. In Paper II, a set of biomarkers was measured to evaluate the toxicity in relation to 
arsenic exposure. In this sense, the umbrella term “toxicity biomarkers” was used. Although 
broader in definition, and somewhat unspecific, it does not make assumptions regarding the 
type of toxicity exerted. In Paper III, an exploratory approach was taken to potentially identify 
novel biomarkers. 
The use of biomarkers of effect is specifically valuable in the context of the Bolivian study area 
because there are no registries on disease outcomes nor extensive clinical records available in 
these rural communities. However, precisely because of this lack of clinical health outcomes, 
it is not possible to distinguish whether the changes observed are truly signs of toxicity or 
adaptive responses at a cellular level. Additional studies will be required to fill the gaps 
between the arsenic-related molecular effects and potential clinical outcomes. 
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4.5.1 Telomere length and mitochondrial DNA copy number 
In Paper II, arsenic toxicity was evaluated by assessing if telomere length and mitochondrial 
DNA copy number (mtDNAcn), two toxicity biomarkers widely explored in relation to 
environmental toxicants, were associated with arsenic exposure. 
Telomeres are nucleotide repetitions that protect the end of eukaryotic chromosomes. The 
machinery for DNA replication in eukaryotes cannot replicate the 3’ end of the DNA strand. 
Therefore, each time a cell divides, telomeres are gradually shortened. To counteract this, 
telomeres are elongated by the telomerase (Blackburn, 2005). The gradual shortening of 
chromosomes may lead to genomic instability (Blackburn, 2005), while longer telomeres 
confer an extended replicative capacity to cells linked to carcinogenesis (McNally et al., 2019). 
In fact, the gene coding for the telomerase is overexpressed in the majority of cancers but it has 
very limited expression in most somatic cells after birth (Jafri et al., 2016). 
Mitochondria, the main energy-producing organelle in eukaryotic cells, have multiple copies 
of extra-nuclear circular DNA. The mtDNAcn increases in response to oxidative stress (Lee et 
al., 2000), which can be generated naturally during cellular respiration by the mitochondria 
itself or due to external toxic insults. Therefore, it is used as a biomarker of oxidative stress. 
Telomere length and mtDNAcn were determined using quantitative polymerase chain reaction 
(PCR) in peripheral blood leukocytes (Cawthon, 2002; Xing et al., 2008). Relative values of 
telomere length and mtDNAcn were calculated as the ratio with a single-copy gene 
(hemoglobin beta, HBB). Therefore, values have arbitrary units, which might limit the 
comparability of the results among different populations and studies. Furthermore, to account 
for inter-plate variation, the ratio for each sample and biomarker was normalized to a reference 
sample included in all run plates. 
4.5.2 8-oxo-dG and 4-HNE-MA 
Oxidative stress has multiple molecular targets at a cellular level, including DNA and lipids. 
As a biomarker for oxidative damage of DNA, 8-oxo-2'-deoxyguanosine (8-oxo-dG) 
concentrations were measured in urine (Loft and Møller, 2006). In addition, 4-hydroxy nonenal 
mercapturic acid (4-HNE-MA) concentrations were measured since it is a urinary metabolite 
product of lipid peroxidation (Dalleau et al., 2013). These two biomarkers of oxidative stress, 
8-oxo-dG and 4-HNE-MA, were quantified in urine and studied in relation to arsenic exposure 
as part of Paper II. 
Urinary concentrations of 8-oxo-dG and 4-HNE-MA were measured by liquid chromatography 
coupled with tandem mass spectrometry (LC-MS/MS) at the Division of Occupational and 
Environmental Medicine from the Department of Laboratory Medicine at Lund University, 
Sweden. There is no golden standard on how to adjust these two biomarkers in urine to correct 
for variations of urinary dilution. Therefore, in Paper II, two urinary dilution correction 
methods and approaches were evaluated in relation to these biomarkers: (i) urinary 
concentrations adjusted for specific gravity or osmolality, and (ii) specific gravity or osmolality 
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included as a covariate in the linear regression models. The associations between these two 
biomarkers of oxidative stress and arsenic exposure were not dependent on which correction 
method was used (described in Paper II). Considering that, and the fact that we adjusted U-As 
with urinary osmolality throughout this thesis work, these two biomarkers were also adjusted 
to the mean urinary osmolality of the study group. 
4.5.3 Identifying potential novel biomarkers 
Sections 4.5.1 and 4.5.2 describe well-established biomarkers of toxicity that have been 
explored to different extents in the scientific literature in relation to arsenic. In Paper III, 
making use of a commercial multiplex proteomic technology, an exploratory study was 
conducted to evaluate how arsenic exposure was associated with a panel of proteins putatively 
related to cancer. Multiplexing technologies enable studies of a more exploratory nature 
expanding the capacity to identify novel biomarkers. 
In Paper III, the Proximity Extension Assay (PEA) technology was performed by Olink 
Proteomics (Uppsala, Sweden). For this, 92 proteins related to cancer processes included in a 
predefined panel (Proseek Multiplex Oncology II panel) were measured in urine. For each 
targeted protein, two protein-specific antibodies are labeled with DNA oligonucleotides. As 
these antibodies bind to the protein of interest, the oligonucleotide labels are close enough to 
hybridize and form a double-strand DNA that is then amplified and quantified by real-time 
PCR. The results are relative protein expression levels in log2 scale (Normalized Protein 
eXpression values, NPX). 
The advantages of this technology are the small sample volume required (1 µL), its increased 
sensitivity, and the dual recognition that minimizes cross-reactivity and non-specific signals. 
However, since protein levels are expressed as relative values, it is not possible to compare 
absolute concentrations between the different proteins and between other studies. This assay 
was initially developed to detect proteins in plasma samples, not in urine (Assarsson et al., 
2014). Therefore, out of the 92 proteins initially measured, 45 proteins were explored in relation 
to arsenic, i.e., proteins with more than 40% of the observations above the limit of detection. 
4.6 GENOTYPING 
Genetic variations across the human genome are responsible, to some extent, for the phenotypic 
variations that are observed. Determining how a group of individuals differs genetically within 
or across populations helps identify which genetic variations explain differences in the 
phenotype and allows us to understand past demographic changes of a population. Single 
nucleotide polymorphisms (SNP) are changes in one base pair, and these are the most common 
type of genetic variation in the human genome. Different genotyping techniques, that is, 
determining which combination of alleles an individual has at a specific SNP locus, are 
described in the following sections based on their throughput capacity. 
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4.6.1 TaqMan allelic discrimination assay 
The TaqMan allelic discrimination assay is based on the hybridization of DNA probes, 
followed by a quantitative PCR. Each SNP assay includes two allele-specific probes coupled 
with different fluorophores to genotype one specific SNP. This assay depends on the 
5’ exonuclease activity of the Taq DNA polymerase combined with fluorescence quenching: 
the probe has a fluorescent reporter molecule (fluorophore) and a quencher in proximity, 
preventing the fluorophore from emitting its signal. Once the probe is bound to the DNA 
template, the polymerase cleaves the probe as it replicates, physically separating the quencher 
and the fluorophore and allowing the latter to emit its fluorescence signal. 
In Paper II, we genotyped SNP rs3740393, located in intron 6 of AS3MT, as it is known to 
predict arsenic metabolism efficiency (Agusa et al., 2011; Drobná et al., 2013; Engström et al., 
2011). Genotyping was done by allelic discrimination using the LightCycler 480 II instrument 
(Roche). 
4.6.2 SNP arrays 
A SNP array is a DNA microarray where DNA probes, covering an extensive set of SNPs 
throughout the genome, are attached to a solid platform. These SNP arrays enable 
whole-genome genotyping following PCR-free protocols (Gunderson et al., 2005). 
Genome-wide genotyping of autosomal chromosomes was performed on the Illumina Infinium 
Omni5Exome (4v1.3) at the SNP&SEQ Technology Platform (Uppsala, Sweden). More than 
4 million SNPs were analyzed in 187 samples from the Bolivian study groups. The SNP data 
were aligned to the human reference genome build version 37 (hg19). Results based on 
genome-wide genotyping are described in Paper IV. 
An advantage of SNP arrays is the small amount of DNA sample required to cover several 
million SNPs. However, it is worth noting that the SNPs contained in these arrays are identified 
mainly in human populations with ancestry from Europe, Asia, and West Africa (Clark et al., 
2005). Therefore, the selection of SNPs in arrays may not reflect the genetic diversity of other 
less-represented populations, such as those from South America. This is referred to as 
ascertainment bias and must be considered when the aim is to identify SNPs that may be 
specific to certain populations, such as those potentially driving arsenic tolerance in Andean 
populations. 
The genotype for SNP rs3740393 was determined with the TaqMan assay (Paper II) and 
within the SNP array (Paper IV) and had a 100% agreement. Map of allelic frequencies was 
made with the Geography of Genetic Variants browser (Marcus and Novembre, 2016). 
4.6.3 Targeted sequencing 
Although SNP arrays cover millions of SNP throughout the genome, the density of SNPs per 
genomic region is still low. In Paper IV, one of the aims was to investigate, by targeted 
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sequencing a candidate region near AS3MT, whether Andean populations had novel SNPs 
potentially missed due to the ascertainment bias of predefined SNP arrays. 
The top SNP associated with urinary %MMA in Schlebusch et al. (2015) in SAC (rs486955 
located at chr10:104546284 upstream of AS3MT, based on hg19) and the 2.5 kilobases (kb) on 
each side defined the candidate region to sequence. A total of 96 individuals were sequenced 
for this region: 24 Aymara-Quechua with high and low %MMA, and all 19 Uru and 
53 individuals from SAC with enough DNA. An initial long-range PCR was performed to 
amplify the region selected and to incorporate primers with barcodes. By adding barcodes to 
the primers, the amplicons from each individual got a unique barcode, and all samples could 
be pooled together for the sequencing (data for each individual was then separated during the 
data processing). The Pacific Biosciences Sequel I system powered by Single-Molecule, Real-
Time (SMRT) technology was used at the National Genomic Infrastructure (NGI)/Uppsala 
Genome Center (Uppsala, Sweden). Data were then analyzed following a bioinformatic 
pipeline proposed by PacBio, including mapping of the reads to a reference genome (hg19), 
quality control, and variant calling. 
By barcoding the samples and pooling them together, a high throughput is achieved. Also, deep 
sequencing of the nucleotides within a defined region can detect known and novel variants, 
while requiring less data management resources than whole-genome sequencing. However, 
since this protocol depends on PCR amplification, it is susceptible to PCR-biased results. This 
means that the PCR amplification has a higher preference for one allele than the other in 
heterozygotic individuals, potentially leading to biased allelic frequencies. 
4.7 POPULATION STRUCTURE 
The comparative populations used to put the Bolivian study group into geographic and 
demographic contexts from a population structure perspective are described in Paper IV. 
4.7.1 Principal component analysis 
Principal component analysis is used to reduce the dimensions of big datasets into smaller 
subsets, or components, which can be more easily explored. It reduces the genetic variation 
into different components, which are then visualized in two- or three-dimensional plots. 
Individuals that are plotted closer to each other are genetically more similar than those that are 
further apart. Therefore, it is commonly used in population genetics to explore genetic distances 
between populations. Often, genetic affinities between populations are driven by geographic 
proximity (see Section 2.2.1) and therefore, the plots commonly reflect the geographic location 
of the populations. 
4.7.2 Ancestry estimation 
In order to quantify the population structure, a model-based estimation of ancestries was carried 
out with ADMIXTURE (Alexander et al., 2009). Based on a maximum likelihood, it infers the 
ancestry of populations through a clustering approach. It calculates the probability of the 
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genotypes observed when using different ancestry proportions. These results are dependent on 
the comparative populations included and should not be overinterpreted (Lawson et al., 2018). 
4.8 SELECTION SCANS 
Selection scans were performed in Paper IV to detect signals of positive selection across the 
genome. The aim was to determine whether the exposure to arsenic over generations in the 
Bolivian Andes has acted as a selective pressure; for example, by examining if alleles 
associated with an efficient arsenic metabolism were more frequent in the Bolivian populations 
than in comparative populations that have not endured the same environmental pressures. The 
process of how the haplotypes were phased, i.e., assigning each allele to the maternal or 
paternal chromosome, and the determination of ancestral alleles for the selection scans are 
described in Paper IV. First- and second-degree relatives were identified and excluded before 
performing the selection scans. The reason for this is that including close relatives will result 
in higher allelic frequencies due to inherited relatedness and not due to positive selection. The 
top 0.5% of the SNPs selected across the whole genome were further explored to find whether 
AS3MT was within 10 kb on each side of each SNP selected. 
4.8.1 iHS and XP-EHH 
If a new random mutation provides a beneficial trait to a certain environment, this mutation 
tends to be selected for and increases in frequency on a population level. These SNPs that are 
under selective pressures will drag along other neutral variants that are in linkage 
disequilibrium forming a haplotype. When the prevalence of this haplotype increases quickly 
in a population due to selection, recombination does not act fast enough to break down the 
haplotype and abnormally long haplotypes appear (Sabeti et al., 2002). Several methods 
explore the extent of haplotype homozygosity to detect long genomic regions of low genetic 
variability in relation to genome-wide levels. 
The integrated haplotype score (iHS) detects de novo selection where the allele selected has 
substantially increased in frequency but has not reached fixation, i.e., the alternative allele is 
still present in the population (Voight et al., 2006). The length of the haplotype selected is then 
compared to the haplotype length of the alternative alleles. The cross population extended 
haplotype homozygosity test (XP-EHH) is based on the same principle but uses a comparative 
population to check the haplotypes of variants near fixation in one population compared to the 
other (Sabeti et al., 2007). In Paper IV, the Bolivian study groups were compared to Peruvians 
from the 1000 Genomes Project. These tests were performed using the R package rehh (Gautier 
and Vitalis, 2012). 
These methods aim to detect hard sweeps of de novo mutations and recent occurrences of 
selection. Hard sweeps happen when a new mutation occurs, and the phenotypic trait linked to 
it is advantageous for individuals exposed to a certain environmental pressure (Figure 7). The 
sudden appearance of new advantageous mutations that get selected along with the neighboring 




While methods based on haplotype homozygosity such as iHS and XP-EHH detect easily hard 
sweeps, other methods based on fixation indexes are better at detecting soft sweeps and older 
selective events. Soft sweeps happen when a preexisting neutral genetic variation becomes 
advantageous after an environmental change (Figure 7). In these cases, the advantageous 
variant might be already present in different haplotypes backgrounds. The genetic pressures 
that increase the frequency of the advantageous SNP will also hitchhike the different 
haplotypes that the variant is present in. This means that more than one haplotype background 
will be favored. This could be the case of preexisting genetic variation that became beneficial 
as humans populated the Andes and encountered an arsenic-rich environment, which could 
have acted as a strong driver of selection. 
Population differentiation is expected to be similar throughout the genome. However, if certain 
variants become beneficial due to a change in the environment, the genetic differentiation 
between populations will increase more in specific genomic regions when selected compared 
to the rest of the genome. Locus-specific branch length (LSBL) is a method based on fixation 
index (FST) values (Shriver et al., 2004). 
Pairwise FST distances measure genetic differentiation between populations based on the 
heterozygosity at each locus. A higher FST value between two populations at a specific locus 
indicates a higher allele frequency difference at this locus. Three-way FST methods include a 
third “outgroup” population to help indicate in which population the frequency difference 
occurred, which is not possible with a pairwise FST measurement. FST values for the three-way 
comparison were calculated using the Weir and Cockerham’s equation on PLINK between the 
Bolivian study groups (Aymara-Quechua and Uru separately), and Peruvians and Han Chinese 
(outgroup) from the 1000 Genomes Project. The divergence at each locus between the three 
populations was calculated as represented in Figure 8. 
Figure 7. Graphical explanation of soft and hard selective sweeps. Each line represents a haploid 
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4.9 STATISTICAL ANALYSES 
The statistical analyses performed are described in detail in Papers I–IV and summarized in 
this section. All analyses were carried out in R using RStudio, with version 3.4.1 and 1.1.383, 
respectively, for Paper I; and version 3.6.2 and 1.1.423 for Papers II–IV. 
Wilcoxon signed-rank test (for continuous variables) and the z-test of proportions (for 
categorical variables) were used to evaluate differences in general characteristics of the study 
group between ethnicities in Paper I. Wilcoxon tests were also performed to evaluate whether 
the toxicity biomarkers differed between ethnicities (Paper II), and whether relative urinary 
protein levels were different among individuals with high vs. low arsenic exposures 
(Paper III). Spearman’s rank correlation tests were performed between (i) factors influencing 
U-As and its metabolites in urine (Paper I), (ii) urinary dilution correction methods (Paper I), 
(iii) arsenic concentrations in different matrices (Paper II), (iv) toxicity biomarkers and arsenic 
exposure (Paper II), (v) covariates that were associated with overall urinary protein variation 
(Paper III), and (vi) urinary proteins associated with B-As (Paper III). 
Linear regression analyses were used through Papers I–IV, either with univariate or 
multivariable-adjusted models. Diagnostic plots of the residuals from the regression models 
were inspected visually, including residuals vs. fitted plots and Q-Q plots. Variables were log2-
transformed when it increased the adjusted R2 and improved the residual plots of the model, as 
was the case for 8-oxo-dG and 4-HNE-MA in Paper II. In Paper I, linear regression models 
were built to explore how U-As and iAs metabolites in urine were predicted by ethnicity, age, 
body weight, fish and meat consumption, and tobacco smoking. Then, the associations between 
arsenic exposure biomarkers and a set of toxicity biomarkers were studied in Paper II, further 
evaluating whether age, hemoglobin, ethnicity, chewing coca leaves, or smoking were also 
associated with the toxicity biomarkers. In Paper III, the extent to which arsenic exposure and 
other covariates explained the variation of urinary proteins was assessed with univariate linear 
regression models by evaluating R2 (the percentage of the variance of the dependent variable 
Figure 8. Locus-specific branch length (LSBL) comparisons performed in Paper IV. The FST estimate 
for each autosomal variant was calculated with the method by Weir and Cockerham. Data from Peruvians 
and Han Chinese were obtained from the 1000 Genomes Project. Bolivians refers to either the Aymara-
Quechua or Uru, calculated separately. 
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explained by the independent variable). Furthermore, the associations of B-As (and other 
covariates identified in the linear regression of principal components) with relative protein 
levels in urine were studied with multivariable-adjusted linear regression evaluating beta 
coefficients. Compared to B coefficients, beta coefficients account for differences in the units 
of the covariates by standardizing the variables. Then, the effect coefficients of the different 
covariates can be compared. 
Then, the associations between genetic variants and the efficiency to metabolize arsenic in the 
Bolivian study group were explored. The relative arsenic metabolite fractions in urine were 
evaluated using linear regression analyses including SNP rs3740393 in AS3MT (Paper II) and 
a set of SNPs included within a protective haplotype around AS3MT (Paper IV). The genetic 
influence on arsenic metabolism efficiency was also assessed at a genome-wide level 
(Paper IV) using the R package GenABEL (v. 1.8) with functions qtscore and egscore, 
adjusting for potential underlying population structure. 
Sensitivity analyses were performed to explore whether extreme values were driving the 
overall associations, whether different methods to correct for urinary dilution resulted in 
varying associations, and whether including other metals correlated previously with arsenic 
concentrations altered the associations. 
Other methods carried out were the linear regression models of principal components to assess 
which factors explained the overall variation of urinary proteins in Paper III, and the 
population structure analyses (see Section 4.7) and selection scans (see Section 4.8) used in 
Paper IV. 
The effect modification by arsenic metabolism efficiency on the associations between arsenic 
exposure and toxicity biomarkers was explored. First, by introducing a multiplicative 
interaction term between U-As or B-As and the rs3740393 genotype in relation to the toxicity 
biomarkers included in Paper II to evaluate their joint effect. Then, the linear regression 
models were stratified by arsenic metabolism efficiency, assessed by (i) rs3740393 genotype 
in Paper II, and (ii) the median of iAs metabolite fractions in urine in Papers II and III. An 
additive effect of the alleles was assumed when stratifying by genotype: individuals that were 
heterozygotic for the SNP were combined with those that were homozygotic for the less-
frequent allele. 
Generally, a p-value below 0.05 was considered as statistically significant. However, there is a 
higher probability of false positives given a fixed significance level as the number of test 
increases. A Bonferroni correction was used in Paper III since a high number of tests were 
performed. Nevertheless, this correction may be too stringent or conservative and assumes 
completely independent tests, which is not necessarily the case if the proteins measured in urine 
do not excrete independently or in the case of highly linked genetic variants. Considering this 
and the fact that the studies included in this thesis have a limited sample size (n = 201 at most), 
it is of foremost importance to evaluate the biological plausibility and relevance of the results 
in connection to their statistical significance by reporting all p-values and confidence intervals. 
 
 37 
The commonly used statistical significant threshold (p = 5 x 10-8) for genome-wide association 
analyses (Fadista et al., 2016) and the Bonferroni correction were considered in Paper IV. 






5 RESULTS AND DISCUSSION 
5.1 CHARACTERISTICS OF THE STUDY PARTICIPANTS 
General characteristics of the individuals included in Papers I–IV are found in Table 2, 
including arsenic concentrations in urine and blood, which are further described in Section 5.2. 
 
Table 2. Characteristics of the study participants presented as median (minimum–maximum). 
Notes: U-As total and sum were adjusted to mean urinary osmolality in the Bolivian study group and to specific 
gravity in SAC. Only 3 Uru men had B-As data. Abbreviations: B-As, arsenic concentration in blood; DMA, 
dimethylarsinic acid; iAs, inorganic arsenic; MMA, monomethylarsonic acid; SAC, San Antonio de los Cobres 
(Argentina); U-As sum, urinary arsenic as the sum of iAs, MMA, and DMA concentrations; U-As total, urinary 
arsenic as the total concentration of all forms. 
 
The women living in villages around Lake Poopó rarely smoked tobacco or consumed alcohol. 
Only two women from the whole study group (n = 201 in Paper I) reported consuming 
alcoholic beverages every other week. Furthermore, only 3% of the women smoked tobacco 
(asked as yes/no in the questionnaire). On the contrary, 73% of the women chewed coca leaves, 
a longstanding practice among Andean communities as part of rituals and to cope with high 
altitude sickness, pain, and symptoms of exhaustion (Rivera et al., 2005). 
 











ethnicities Uru men SAC 
n 
(women) 
201 168 33  193  176  158  
+ 5 men 
















































































































































































On average, these Bolivian women had 3 children and 10% of them had more than 6. Around 
75% of the study group identified themselves as farmers of crops or animals, artisans, 
merchants, or housekeepers. The rest worked either in health services or in schools. 
The median body mass index of these women, described in Paper I, was 27 kg/m2 (range 
16-44 kg/m2). Indigenous communities living in the Andes are shorter (half of the women in
the study group were shorter than 149 cm) and have wider thoraxes than those in the lowlands,
potentially as an adaptation to decreased atmospheric oxygen levels at high altitudes (Espinoza-
Navarro et al., 2011; Harari et al., 2015; Macdonald et al., 2004). As a result, body mass indexes
do not accurately estimate body fat in these populations, and therefore, were not used.
The population structure of the Bolivian study group, assessed separately for the individuals of 
Aymara-Quechua or Uru descent, was explored using genome-wide genotype data in 
Paper IV. The Aymara-Quechua and Uru study groups clustered in the principal component 
analysis with other Andean populations (Figure 9). Individuals belonging to the Uru ethnic 
group clustered furthest away possibly reflecting their historical isolation (de la Barra Saavedra 
et al., 2011). The level of European influence in the genomes of these Bolivian study groups 
was limited: 1.9% and 0.2% of the genetic diversity of Aymara-Quechua and Uru, respectively, 
was of European ancestry. 
Figure 9. Principal component (PC) analyses for indigenous populations in Latin America. The Aymara-
Quechua and Uru in Bolivia and the women from San Antonio de los Cobres (SAC) clustered together
with other populations in the Andes (in brown). The Yoruba and Spanish populations (in purple) were
included to remove African and Spanish admixture in PC1 and PC2 (not shown). Additional description 
of the method and populations is found in Paper IV. 
41 
5.2 ARSENIC EXPOSURE ASSESSMENT 
The environmental exposure to arsenic in the inhabitants of villages situated around Lake 
Poopó, Bolivia was characterized by measuring concentrations of arsenic in urine, blood, and 
drinking water samples. Total concentrations of arsenic in urine can include both metabolites 
of inorganic arsenic (iAs, MMA, and DMA) and less-toxic organic forms (e.g., arsenobetaine) 
of this metalloid. By quantifying the arsenic metabolites separately, also known as arsenic 
speciation, and comparing the sum of them to total arsenic concentrations, it is possible to 
distinguish the major contributing forms to the overall arsenic exposure as done in Paper I. 
In Paper I, the exposure to arsenic was assessed by concentrations in urine samples, the most 
used biomarker of arsenic exposure. The sum of inorganic arsenic metabolite concentrations in 
urine (referred to as U-As in the thesis) and total arsenic concentrations in urine were strongly 
correlated (rS = 0.99, p < 0.001) and in agreement (the ratio between both measurements was 
close to 1). This suggests that the women living around Lake Poopó were exposed mainly to 
inorganic arsenic. Their exposure to inorganic arsenic was varied and elevated: U-As, adjusted 
to urinary osmolality, ranged between 12 and 407 µg/L with a median of 65 µg/L. In addition, 
there was a wide range of U-As across and within villages. Furthermore, the Aymara-Quechua 
women had significantly higher U-As compared to Uru (Table 2). Regarding the choice of 
urinary dilution correction method, a strong correlation (rS = 0.99, p < 0.001) and agreement 
was found between adjusting U-As to osmolality or specific gravity as described in Paper I 
(Figure 6). However, U-As was adjusted to the mean urinary osmolality of the study group 
since it has been recently shown to be an optimal correction method for arsenic concentrations 
(Middleton et al., 2019, see Section 4.4.3). 
The exposure to arsenic in these women was also evaluated in blood in Papers II and III. 
Arsenic concentrations in blood are generally considered as a biomarker of recent exposure 
because arsenic is quickly cleared from this matrix (Hughes, 2006). Nevertheless, in 
populations exposed chronically to arsenic, concentrations of arsenic in blood reach a steady 
state enabling the use of both urine and blood as valid matrices to evaluate arsenic exposure 
(Concha et al., 1998a; Hall et al., 2006; Takayama et al., 2021). The median B-As was 2.0 ng/g 
(range 0.6–9.2 ng/g) in these Bolivian women (n = 193, Paper II). The strong correlation 
between U-As (adjusted for osmolality) and B-As (rS = 0.85, p < 0.001, Figure 10) supports a 
chronic exposure to arsenic in this study group, and it corroborates the validity of using B-As 
as a biomarker of exposure that does not require urinary dilution corrections. 
Arsenic concentrations in water were also measured to characterize the study area and identify 
potential sources of arsenic exposure in Paper I. Arsenic in drinking water samples from 
mostly groundwater sources from the 10 villages included in the study ranged from 3.3 to 
571 µg/L and did not exhibit temporal variations during the years the recruitment took place, 
further supporting a constant exposure to arsenic. Villages where Aymara-Quechua 
communities lived had higher water arsenic concentrations on average (median 130 µg/L, 
range 25–571 µg/L) than that of Uru villages (median 46 µg/L, range 3.3–222 µg/L), possibly 
explaining the difference in arsenic exposure between both ethnicities. In some villages, water 
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samples were collected from several sources and showed a wide variation in arsenic 
concentrations; for example, in Santuario de Quillacas, arsenic concentrations in water ranged 
between 25 and 176 µg/L. This variation in concentrations of arsenic in water within the same 
village, as well as potential differences in water consumption, might explain the variation of 
arsenic exposure of individuals living in the same village. 
 
The arsenic concentrations in the water of each village (average if multiple sources were 
sampled) was weakly correlated with the U-As (adjusted to osmolality) of the inhabitants 
(rS=0.30, p < 0.001). This was not surprising since the water samples collected did not represent 
the individual water consumption of each participant. Another common source of exposure to 
inorganic arsenic is rice, which also may contain some DMA (Meharg et al., 2009). However, 
rice collected from the main markets around Lake Poopó presented low arsenic concentrations 
(Paper I). Therefore, arsenic exposure via drinking water was still considered the main 
exposure source, particularly considering that we did not sample all water sources or 
thoroughly characterize individual water consumption. In addition, even harvested rainwater 
for human consumption, which is presumed to be free of arsenic, has been shown to have 
elevated arsenic concentrations (median 20 µg/L, range 0–50 µg/L) in collection systems 
implemented around Lake Poopó (Quaghebeur et al., 2019). The high arsenic concentrations 
in the rainwater collected were tracked to mineral dust particles with arsenic deposited on the 
roof, an important problem considering the arid climate of the study area. The presence of 




Figure 10. Scatter plots with loess line of B-As and U-As, not adjusted and adjusted to mean urinary 
osmolality to correct for urinary dilution variations. Abbreviations: B-As, arsenic concentration in blood; 
U-As, urinary arsenic as the sum of inorganic arsenic metabolite concentrations. 
rS = 0.66, p < 0.001 rS = 0.85, p < 0.001 
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Papers I and II provide the most complete and thorough characterization of ongoing arsenic 
exposure in Bolivia up to date. Since Paper I was published in 2019, no new studies have 
evaluated arsenic exposure in humans in any other Bolivian region, highlighting the need for 
additional efforts. 
5.3 ARSENIC METABOLISM AND INFLUENCING FACTORS 
The efficiency to metabolize arsenic of the Bolivian women was evaluated in Paper I. 
Indigenous women living in villages around Lake Poopó had an efficient arsenic metabolism 
characterized by low urinary fractions of MMA, the form generally associated with most 
adverse health effects. The median relative fractions of inorganic arsenic metabolites in urine 
for this study group (when combining Aymara-Quechua and Uru women) were 12% iAs, 7.7% 
MMA, and 80% DMA (Figure 11). This distribution of metabolites in urine is different 
compared to the average across other populations with 10–30% iAs, 10–20% MMA, and 
60-80% DMA (Vahter and Concha, 2001). The arsenic metabolism capacity in the Bolivian 
women was similar to that previously described in women from SAC in the Argentinean Andes 
with a median 7.5% MMA in urine (Schlebusch et al., 2015). No other population, apart from 
these in the Argentinean and Bolivian Andes, have been described as such efficient arsenic 
metabolizers. This opens the question to whether this efficient arsenic metabolism is specific 
to indigenous populations from the Andes or whether it is present elsewhere. 
 
 
Figure 11. Distribution of inorganic arsenic metabolite fractions in urine in different populations.
SAC 1995 and 2015 refer to women from San Antonio de los Cobres (SAC), Argentina described in
Vahter et al. (1995) and Schlebusch et al. (2015), respectively. The Aymara-Quechua and Uru are 
described in Paper I, and most populations refers to an average across populations described in Vahter










































Factors known to influence the body’s capacity to methylate arsenic were explored with 
multivariable-adjusted linear regression in Paper I. Body weight, the consumption of fish, 
smoking of tobacco, and ethnicity were associated with differences in arsenic metabolism 
efficiency in the Bolivian study group. Smoking tobacco, although highly infrequent in this 
study group, was associated with a less efficient arsenic methylation, i.e., higher %iAs and 
%MMA. On the contrary, fish consumption (reported as yes/no) and body weight (possibly 
reflecting more protein intake in this context) were associated with a more efficient arsenic 
metabolism. Higher arsenic exposure is known to impair the metabolism of arsenic (Li et al., 
2008; Lindberg et al., 2008a); however, this was not the case in the Bolivian or Argentinean 
study groups. Interestingly, ethnicity was associated with all three inorganic arsenic metabolite 
fractions, even after adjusting for differences in arsenic exposure by including U-As in the 
models. On average, Uru women had 2.5 percentage unit (%) lower %iAs, 2.2 lower %MMA, 
and 4.7 higher %DMA, suggesting a more efficient metabolism than the Aymara-Quechua. All 
in all, these models including ethnicity, body weight, fish and tobacco consumption, and U-As 
explained between 11 and 26% of the variability in the arsenic metabolite fractions in urine, 
indicated by the R2 estimates of the linear regression models. This indicates that other factors 
also determine the body’s capacity to metabolize and excrete arsenic. 
Ethnic differences in arsenic metabolism capacity have not been explored extensively. While 
differences in arsenic exposure have been identified across ethnic groups living in the United 
States (Jones et al., 2019), no significant differences in arsenic methylation efficiency were 
seen among non-Hispanic White, African American, Hispanic, and Chinese American groups 
exposed to low concentrations of arsenic in the United States (Balakrishnan et al., 2018). No 
differences in urinary %MMA were found between Hispanic and non-Hispanic individuals 
from the southwest United States and northwest Mexico either (Gomez-Rubio et al., 2011). In 
contrast, a study comparing Chinese populations found that Tibetans had a more efficient 
arsenic metabolism than Han and Hui Chinese individuals (Fu et al., 2014). However, the 
Tibetans in this study had high %MMA (median 25%) compared to other global populations. 
 
What does it mean to have an efficient arsenic metabolism? 
When humans are exposed to inorganic arsenic, for example through drinking 
water, it gets metabolized in the liver by adding one or two methyl groups to it. The 
three arsenic forms (monomethylated, dimethylated and remaining un-methylated 
arsenic) are excreted in urine. Generally, the dimethylated form (DMA) is better 
excreted, while the monomethylated one (MMA) is considered more toxic. Lower 
fractions of MMA and higher of DMA in urine are considered a sign of an efficient 
arsenic metabolism. Up until now, only indigenous groups in the Andes have been 
described as efficient arsenic metabolizers at a population level. 
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Genetic polymorphisms in AS3MT, which codes for the main arsenic methylating enzyme, are 
known to predict arsenic methylation efficiency. In Paper II, SNP rs3740393 in AS3MT, 
previously associated with arsenic methylation (Agusa et al., 2011; Drobná et al., 2013; 
Engström et al., 2011), was studied in relation to arsenic metabolism efficiency in the Bolivian 
study group. Genotype CC of rs3740393 was associated with lower urinary %MMA, i.e., a 
more efficient arsenic metabolism. This finding is in line with other studies from, for example, 
Argentina and Bangladesh (Engström et al., 2011), Mexico (Drobná et al., 2013), and the 
United States (Balakrishnan et al., 2017). 
The implication of AS3MT on arsenic metabolism was further explored throughout the whole 
gene. Polymorphisms along AS3MT are in high linkage disequilibrium (Engström et al., 2013; 
Gomez-Rubio et al., 2010). This means that SNPs within and near AS3MT are not inherited 
independently, but instead as a haplotype block. In the Argentinean women described 
previously as efficient arsenic metabolizers, 52 SNPs were associated at a genome-wide level 
with urinary %MMA forming what was defined as a protective haplotype (Schlebusch et al., 
2015). 
Using SNP array data from the Bolivian study group (n = 187), a protective haplotype based 
on the one from the Argentinean group was defined as a candidate region in Paper IV. From 
the 52 SNPs conforming the protective haplotype in Argentina, 35 SNPs were present in the 
Bolivian dataset after filtering and merging. This protective haplotype is located in 
chromosome 10 (chr10:104,315,215-10:104,852,121, hg19) and includes AS3MT among other 
genes (Figure 12). In Paper IV, SNPs within the protective haplotype were associated with 
arsenic metabolite fractions in the Bolivian study group, but to a lesser extent than in SAC. 
This could be explained by the Bolivian study group having a lower variation in urinary 
%MMA than the women in SAC, and due to higher-than-expected frequency of the protective 
variants. Furthermore, genome-wide association analyses did not find any clear signals or 
significant associations, beyond the significant threshold, with arsenic metabolite fractions. 
How is the AS3MT protective haplotype defined? 
It is a combination of alleles that were associated with lower MMA fractions in 
urine in an indigenous population from San Antonio de los Cobres, in the Argentinean 
Andes. This combination of alleles located on the same chromosome, either maternal 
or paternal, is known as haplotype. It is considered protective because a lower MMA 
fraction in urine is linked to less adverse health effects related to the toxicity of arsenic. 
This protective haplotype includes alleles within AS3MT, the main methylating 
enzyme, as well as WBP1L, CYP17A1, and CNNM2, among others. 
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5.4 MOLECULAR EFFECTS OF ARSENIC EXPOSURE 
Arsenic causes toxicity via a plethora of mechanisms of action at a molecular level. Driven 
mainly by the metalloid’s capacity to bind to sulfhydryl groups, arsenic inhibits protein 
function and induces oxidative stress. The health consequences of arsenic exposure in the study 
area are widely unexplored and unknown. Considering the setting and how medical services 
are organized in these remote villages, thorough longitudinal studies are not currently feasible, 
and no clinical data are available. Instead, toxicity biomarkers were used to study the effects of 
arsenic. Despite these women at a population level being efficient at metabolizing arsenic, 
Bolivian women had molecular signs of arsenic-related toxicity, particularly in individuals with 
a less efficient metabolism. 
In Paper II, the associations between arsenic exposure, assessed in two matrices (urine and 
blood), and traditional toxicity biomarkers were explored (Figure 13). The toxicity biomarkers 
included were telomere length and three related to oxidative stress, i.e., mtDNAcn, 8-oxo-dG, 
and 4-HNE-MA. Long telomeres and higher mtDNAcn were associated with arsenic exposure 
in the Bolivian study group. This association between arsenic exposure and longer telomeres 
has been previously described (Ameer et al., 2016; Gao et al., 2015a; Herlin et al., 2019; 
Jimenez Villarreal et al., 2019), as well as for higher mtDNAcn (Ameer et al., 2016; Sanyal et 
al., 2018). 
Concentrations of 4-HNE-MA, a urinary metabolite of lipid peroxidation, were positively 
associated with U-As and B-As. Only two other studies have studied 4-HNE-MA in relation to 
arsenic exposure, and both found a positive association between U-As and 4-HNE metabolites 
in urine (He et al., 2020; Kozłowska et al., 2019). 
 
Figure 12. Genomic location of the protective haplotype associated with lower urinary %MMA in San 
Antonio de los Cobres, Argentina as described in Schlebusch et al. (2015). The protective haplotype is 
located at chr10:104,315,215-10:104,852,121 (based on the human reference genome version 37, hg19). 
Top SNP associated with urinary %MMA was rs486955 in Argentina (Schlebusch et al., 2015), and 
rs17115100 in Bolivia (Paper IV). Illustration of chromosome 10 obtained from UCSC Genome 
Browser (https://genome.ucsc.edu).  
Protective haplotype ≈ 500 kb 

















Higher concentrations of 8-oxo-dG in urine, a biomarker of DNA damage induced by oxidative 
stress, were positively associated with U-As but inversely associated with B-As. A positive 
association between U-As and urinary 8-oxo-dG has been repeatedly described (Breton et al., 
2007; Chou et al., 2014; Engström et al., 2010a, 2010b; Fujino et al., 2005; Kubota et al., 2006; 
Mar Wai et al., 2019). However, there are also studies reporting discrepant results depending 
on the biomarker of arsenic exposure used (Breton et al., 2007; Burgess et al., 2007). The 
positive association with U-As could be a consequence of co-excretion between the biomarker 
of exposure and toxicity in urine, previously described for other metals like cadmium (Wallin 
et al., 2014). It also highlights the need to properly understand whether 8-oxo-dG 
concentrations in urine reflect DNA damage. Based on these contradictory results, B-As was 
chosen as biomarker of exposure in Paper III. 
The efficiency to metabolize arsenic was evaluated as an effect modifier for the association 
between arsenic exposure and these toxicity biomarkers in Paper II. The hypothesis was that 
individuals with a less efficient arsenic metabolism were more likely to show arsenic-related 
toxicity. Arsenic exposure was associated with longer telomeres and higher mtDNAcn 
particularly in women with a less efficient metabolism (Figure 13). This was previously 
described in the study group from SAC in the Argentinean Andes (Ameer et al., 2016). No 
clear effect of the arsenic metabolism capacity was seen for the urinary concentrations of 
8-oxo-dG or 4-HNE-MA. Contrary to expected, efficient arsenic metabolizers, i.e., those with
lower urinary %MMA, had higher urinary 4-HNE-MA concentrations with increasing B-As.
It is speculated that there could be an interaction between the metabolic pathways of arsenic
and 4-hydroxy nonenal since both depend on glutathione.
Figure 13. Predicted values (marginal effects of interaction terms) and 95% confidence intervals for
adjusted linear regression models between toxicity biomarkers and arsenic exposure. Toxicity
biomarkers (8-oxo-dG and 4-HNE-MA) and arsenic concentrations (U-As) measured in urine were 
corrected to mean urinary osmolality. Telomere length and mtDNAcn are relative values and have
arbitrary units. Models were adjusted as described in Paper II. See Section 5.5 for a description of
rs3740393. Abbreviations: 4-HNE-MA, 4-hydroxy nonenal mercapturic acid; 8-oxo-dG, 8-oxo-2’-
deoxyguanosine; B-As, arsenic concentration in blood; mtDNAcn, mitochondrial DNA copy number;
U-As, urinary arsenic as the sum of inorganic arsenic metabolite concentrations.
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In Paper III, an exploratory approach was taken to evaluate whether a panel of 
92 cancer-related proteins were associated with B-As. Out of the 92 proteins putatively related 
to cancer processes included in a predesigned panel, 45 proteins (those with more than 40% of 
observations above the limit of detection within each protein) were included in downstream 
analyses. Arsenic exposure, as B-As, was associated with the relative expression of four 
proteins measured in urine: tumor necrosis factor ligand superfamily member 6, FASLG; 
seizure 6-like protein, SEZ6L; Ly6/PLAUR domain-containing protein 3, LYPD3; and tissue 
factor pathway inhibitor 2, TFPI2 (Figure 14). Only FASLG has previously been linked to 
arsenic exposure in epidemiological studies. FASLG participates as a promotor and inhibitor 
of signaling pathways related to apoptosis, depending on the type of cell (Bossi et al., 2000). 
High concentrations of soluble FASLG in serum have been found in individuals with different 
types of cancer (Kadam and Abhang, 2016). In vitro studies have found an increased gene or 
protein expression of FASLG in leukemia cell lines treated with arsenic trioxide, a cancer drug 
currently used to treat acute promyelocytic leukemia (Toosi et al., 2018; Zeng et al., 2016; Zhu 
et al., 2003). Interestingly, the gene expression of FASLG was elevated in the indigenous 
women from SAC in the Argentinean Andes that were highly exposed to arsenic (Engström et 
al., 2017). 
Paper III is a cross-sectional study with no clinical outcomes included. Therefore, it is not 
possible to distinguish with certainty whether the findings are related to arsenic toxicity per se 
or are a consequence of an adaptive response that will not translate into adverse health 
outcomes. The associations between B-As and the four proteins were similar across arsenic 
metabolism efficiency strata. If stronger associations had been found among the less efficient 
arsenic metabolizers, which are more susceptible to arsenic toxicity, it would have supported 
that the changes in these proteins were because of arsenic toxicity. Nevertheless, the findings 
in Paper III serve as a starting point to determine novel biomarkers in future studies including 
clinical outcomes in relation to arsenic exposure. In addition, it promotes the potential that 
urine has as a non-invasive matrix in biomarker discovery. 
Figure 14. Predicted values (marginal effects of interaction terms) and 95% confidence intervals for 
adjusted linear regression models between the top four cancer-related proteins in urine associated with 
B-As. Models were adjusted as described in Paper III. Low urinary %MMA refers to individuals with
%MMA below or equal the median, while high %MMA refers to above the %MMA median.
Abbreviations: B-As, arsenic concentration in blood; MMA, monomethylarsonic acid.
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Factors that influenced protein variation in urine were evaluated in Paper III using linear 
regression models of principal components. The overall protein variation was explained by 
differences in age, urinary osmolality, leukocytes in urine, and urinary pH. These factors were 
included as covariates when evaluating the associations between relative protein levels and 
B-As. Coca chewing, ethnicity, sampling date, and other data from the urine strip were not 
influencing factors. To evaluate how different factors explained the protein levels at an 
individual level, univariate models were used. The variation of most proteins measured in urine 
was explained by urinary osmolality, for some proteins explaining up to 49% but not being so 
influential for FASLG.  
Studies on arsenic-related cancer in Latin America have focused mainly on Chile, Argentina, 
and Mexico (Khan et al., 2020). Very limited information is available regarding the health 
effects of arsenic in populations with an efficient arsenic metabolism such as the ones described 
in the Andes in Paper I and by Vahter et al. (1995). This, and the fact that cancer prevalence 
varies across populations (Lorenzo Bermejo et al., 2017), emphasizes the need for 
population-specific studies. Several outcomes have been studied in relation to arsenic exposure 
in the Argentinean women with a highly efficient arsenic metabolism living around SAC. 
However, these outcomes were all biomarkers of effects, and not clinical. For example, arsenic 
exposure was associated with an increased frequency of micronuclei in lymphocytes (Dulout 
et al., 1996); lower blood pressure, lower ratios of apolipoprotein B/A, and lower hemoglobin 
in blood (Ameer et al., 2015); and longer telomeres and higher mtDNAcn particularly in the 
subgroup of individuals with a less efficient arsenic metabolism (Ameer et al., 2016). These 
results, together with findings from Papers II and III, suggest that arsenic exposure can lead 
to toxic outcomes even in populations that are described, on average, as efficient arsenic 
metabolizers. However, no signs of hyperkeratosis or pigmentation changes of the palms were 
ever seen in these Argentinean women, which is interesting since these often are the first signs 
of chronic inorganic arsenic exposure (Concha et al., 1998a; Vahter et al., 1995). 
5.5 GENETIC ADAPTATION TO ARSENIC EXPOSURE 
The Bolivian women from the study group were shown to be efficient at methylating arsenic 
in Paper I. Then, in Paper II, the genetic variant rs3740393 in AS3MT was associated with 
arsenic metabolite fractions in urine: individuals with genotype CC had lower urinary %MMA, 
an indication of a more efficient arsenic metabolism. Furthermore, the C-allele of this SNP was 
at a higher frequency in the Bolivian study group (79%) than in other populations exposed 
chronically to iAs in Chile (68%; Apata et al., 2017) or Argentina (70%; Engström et al., 2011), 
and other populations worldwide (Figure 15). In Paper IV, the frequency of the protective 
haplotype, predefined based on SNPs associated with lower urinary %MMA in SAC 
(Schlebusch et al., 2015), was similar in SAC and in the Aymara-Quechua group (63% and 




The high frequency of alleles associated with a beneficial trait can be a consequence of strong 
selective pressures in the environment modulating the allelic frequencies in a population. 
Therefore, genome-wide selection scans were carried out to test for signs of positive selection 
across the genome in Paper IV. Signals near AS3MT were within the top selected regions 
throughout the genome in the Aymara-Quechua and Uru groups, supporting the hypothesis that 
these Bolivian study groups have genetically adapted to eliminate arsenic more efficiently. 
Indications of a selection for increased detoxification of arsenic were first found in indigenous 
populations from the Andes living in Argentina (Schlebusch et al., 2015). Since then, smaller 
and less comprehensive studies with individuals across the Andes have reported changes in the 
frequency of alleles associated with a more efficient arsenic metabolism, as well as signs of 
selection near AS3MT (Apata et al., 2017; Eichstaedt et al., 2015; Jacovas et al., 2018). 
However, none of these studies included phenotypic data on arsenic methylation. 
Genome-wide selection scans, as the name implies, serve to identify possible regions of the 
genome that have been subjected to positive selection. This alone does not necessarily translate 
to tolerance or adaptation, which require of a biological and environmental context to be able 
to interpret the results. The notion of adaptation to tolerate arsenic in indigenous populations 
in the Andes is supported by (i) the signals of positive selection near AS3MT in Paper IV that 
have led to (ii) the high frequencies of alleles associated with a more efficient arsenic 
metabolism, which (iii) is evident from phenotypic analyses in Paper I. 
Adaptation takes place over the course of multiple generations. Therefore, putting arsenic 
exposure into an historical context helps understand how a potential adaptation to tolerate 
arsenic occurred. Evidence of environmental arsenic exposure for centuries in the Andes is 
supported by traces of arsenic in pre-Hispanic mummies from Chile (Arriaza et al., 2010; 
Echeverría et al., 2018; Kakoulli et al., 2014). Epidemiological studies indicating arsenic 
exposure is associated with higher child mortality and morbidity (Hopenhayn-Rich et al., 2000; 
Rahman et al., 2010; Shih et al., 2017; Smith et al., 2012) suggest arsenic as a strong selective 
pressure capable of shaping the survival chances and therefore, allowing beneficial traits to 
increase in frequency over generations. It is worth noting that the present exposure to arsenic 
in the Bolivian study groups may not reflect their exposure in the past, which could have been 
even higher and driving the selection. 
The selection of a more efficient arsenic metabolizing phenotype in the Andean populations 
has likely risen from standing genetic variation. This means that the genetic variants 
responsible of the advantageous trait existed in the population before the individuals 
encountered the environmental stressor. This idea is supported by the fact that stronger 
selection signals are identified with allele frequency selection scans instead of haplotype-based 
methods (see Section 4.8 for more details). In addition, the protective haplotype is also 
observed in East Asian populations, although at a lower frequency (Schlebusch et al., 2015). 
The presence of the protective haplotype in other parts of the world supports the notion that the 




Although signs of positive selection related to arsenic detoxification have been identified across 
populations in the Andes, the functional variant(s) and exact mechanism driving this selection 
are still unknown. A haplotype in high linkage disequilibrium spanning up to 600 kb around 
AS3MT has been detected in Argentinean (Schläwicke Engström et al., 2009) and Mexican 
populations (Gomez-Rubio et al., 2010). While this facilitates the detection of signals in 
whole-genome association studies, it hinders the identification of the functional variant(s). 
In Paper IV, targeted sequencing around the top SNP associated with urinary %MMA in SAC 
was used to explore the presence of genetic variants not captured in the SNP array in 
Argentinean and Bolivian individuals. Twelve SNPs, out of which three were included in the 
SNP array, were found within the 4.8 kb region sequenced, and all had been previously 
identified in SNP databases. The associations of these SNPs with arsenic metabolism efficiency 
should be further evaluated. 
Recently, a study including targeted sequencing data identified 13 rare variants (<1% allelic 
frequency) in the coding regions of AS3MT that were associated with a less efficient arsenic 
metabolism, indicated by lower %DMA, across three arsenic-exposed study groups (Delgado 
et al., 2021). It will be interesting to explore the consequences of these rare variants in coding 
regions on arsenic toxicity. However, human traits are usually complex and commonly 
explained by a collection of genetic variants, each of them contributing partially in an additive 
manner. Therefore, it could be that several non-coding genetic variants near AS3MT have a 
combined effect on, for example, the gene expression of AS3MT. 
 
 
Figure 15. World map with allelic frequencies of SNP rs3740393 in AS3MT. Data from Argentina 
obtained from women from San Antonio de los Cobres as reported in Engström et al. (2011). Data from 
Bolivia is the combination of Aymara-Quechua and Uru women described in Paper II. Map made with 






5.6 METHODOLOGICAL CONSIDERATIONS 
The sample sizes of the studies included in this thesis are small, including between 163 and 
201 individuals. Despite the apparent small sample size, recruitment took place in all Uru 
villages around Lake Poopó and in several Aymara-Quechua villages in the region. These 
villages are small in general; however, a precise estimate of the total population in each village 
was not available. When we asked at the local health centers for an estimation of the population 
size, in those villages that did have some type of register, we were warned that they were not 
accurate. This was because there was a large discrepancy between those officially registered in 
the village versus those that actually lived there and could have been reached. Recruiting in 
these remote rural villages of the Bolivian Andes is challenging. For example, the physical 
access via road to the villages was limited, all the materials and resources had to be transported 
to each village, and in some cases, we even had limited access to electricity. In this context, a 
convenience sampling was the only feasible solution. Therefore, an exact participation rate 
could not be calculated. 
A potential source of bias, or systematic error, can occur during the selection of participants. 
However, it was not expected that women with higher levels of arsenic were more likely to 
participate since they did not have knowledge of their own arsenic exposure beforehand. In 
addition, since it was a cross-sectional study, causal relationships could not be concluded. 
Furthermore, increasing the sample size reduces random errors, i.e., those affecting the 
estimation of the effects. However, to overcome this, confidence intervals were included to 
indicate the precision of the estimates, and we were aware of this limitation when interpreting 
the results. 
A novelty and strength of this thesis is the inclusion of several ethnic groups from the Bolivian 
Andes, the Aymara-Quechua and Uru, the latter highly underrepresented in the scientific 
literature. Ethnicity was assessed based on the location of residency of the participant and 
where their family members came from, which was feasible considering the limited contact 
between villages of different ethnicity. Ethnicity is a social construct, and its inclusion in 
epidemiological studies regarding environmental exposure has a set of considerations 
(Benmarhnia et al., 2021). In the projects included in this thesis, ethnicity served as a proxy for 
differences in lifestyle or exposures, as well as a reflection of distinct populations from a 
specific genetic perspective. Genetic differences between ethnicities might influence the 
capacity to metabolize arsenic, as well as other processes involved in how the metalloid exerts 
its toxicity, e.g., polymorphisms in genes related to oxidative stress management. In Paper I, 
ethnicity was included as a covariate to understand whether the capacity to methylate arsenic 
was different in each ethnic group. In Paper II, ethnicity was used as a confounder: both 
exposure (arsenic concentrations) and outcome (urinary concentrations of toxicity biomarkers) 
were different between ethnicities, and ethnicity is not a consequence of the arsenic exposure. 
Arsenic exposure in this study group was characterized with accurate and reliable ICP-MS 
methods and the use of two matrices, blood and urine. Therefore, the risk of exposure 
misclassification, a type of information bias, is somewhat reduced. Furthermore, a wide range 
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of U-As permits the use of linear regression models with a quantitative exposure, especially 
since it was not possible to identify other villages in the region that were not exposed to arsenic. 
Unidentified confounders can mask or falsely show associations, another type of systematic 
error. The fact that women in this study group did not smoke or consume alcohol to a great 
extent avoided additional potential confounders. However, it must be noted that other 
unidentified confounders can still exist. Another type of information bias can arise from how 
the variables related to food intake were defined. Our questionnaire was not intended to be a 
dietary questionnaire, and therefore, in Paper I the variables were used mostly to describe the 
general eating habits across the villages and ethnic groups. 
In Paper II, and specifically Paper III, it is hard to disentangle whether the changes observed 
regarding the toxicity biomarkers and protein levels are in fact a toxic response or a 
consequence of adaptive mechanisms in the organism. Nevertheless, the findings still provide 
important insights by identifying potential signs of molecular toxicity and guide future research 
within biomarker discovery in urine. Furthermore, the exposure to other metals, pesticides or 
air pollutants can also contribute to oxidative stress and should be considered in future studies. 
As a pilot analysis, we evaluated 11 pesticide metabolites in urine of a subset of 59 Bolivian 
women and concluded that they were not highly exposed. However, it could be that the 
pesticides selected did not reflect the ones they used. 
Multiple testing also contributes to random error. The more tests performed, the higher the risk 
of chance findings, also known as false positives. However, for this to happen the tests should 
be independent, which is not entirely the case for the proteins measured in Paper III or the 
genetic variants explored in Paper IV. In any case, considerations for multiple testing were 
included in Papers III and IV. At the same time, there is also a risk for false negatives because 
of the low frequency of the alleles and the small sample size of these study groups. 
Consequently, special attention must be focused on interpreting the plausibility of the findings 




5.7 ETHICAL CONSIDERATIONS 
Ethical permits were granted from ethical committees in Sweden, Bolivia, and Argentina to 
perform the studies included in this thesis. The considerations in this section are described 
within the context of the Bolivian project since I personally participated in all processes of the 
study, from visiting the villages and helping recruit the participants, to data analyses and 
reporting of the results. However, they also apply to the part of the project carried out with data 
from Argentina included in Paper IV to identify novel AS3MT variants. 
This cross-sectional study consists of people from three ethnic groups living around Lake 
Poopó: Aymara and Quechua (combined as Aymara-Quechua, see Section 4.2) and Uru. The 
Aymara and Quechua are the most predominant indigenous groups in the study area. On the 
contrary, the Uru communities around Lake Poopó are secluded to a few villages with a long 
history of social and economic exclusion. The interaction between researchers and study 
participants needs to rely on trust, clear understanding of the research intentions, and 
transparency. With this purpose, multiple socialization activities took place before, during, and 
after the recruitment, for example, information meetings and dynamic workshops with the 
inhabitants using visual aids such as the on-site arsenic detection kits. All this, while extending 
the length and difficulty of the recruitment, contributes to the connection between the 
participants and the researchers. 
The project was explained orally and in written form to potential participants to guarantee that 
they understood the purpose of the study and what it entailed. This was especially important in 
cases where older or illiterate people wanted to participate. Before taking samples or 
interviewing the participants, oral and written consent was obtained. We explained that their 
participation was voluntary, and that they had the right to withdraw from the study without 
requiring an explanation and emphasizing that there were no negative consequences if doing 
so. Participants had the chance to ask questions to the researchers during the visits. The same 
villages were visited several times which allowed the participants to solve further doubts and 
discuss the results. In addition, contact information to the researchers in Bolivia was given, and 
we collaborated with a local doctor who was working in the area and could answer any 
questions while we were not there. 
During the recruitment, blood and urine samples were taken, and we interviewed the 
participants. This could induce stress to the participants, especially if they were uncomfortable 
with needles, and implied that they invested part of their time to collaborate with us. In return, 
we did not offer gifts or economical compensation. Instead, we performed a quick on-site health 
assessment, and the results were directly given to the participants. This included determination 
of blood pressure, urinary tract infection analysis, glucose determination in urine as an indicator 
of diabetes, and hemoglobin data to assess iron status. Since health professionals and the 
medical services in the villages are normally very limited, this approach was considered more 
beneficial and relevant for the participants. Information about the arsenic concentrations in 
drinking water sources from the different villages was given to the health centers and local 
authorities. In addition, personalized letters with information about individual exposure to 
arsenic were prepared and delivered to the participants through the local health providers. 
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Finally, how to handle genetic information is of utmost importance and an ongoing debate. As 
mentioned to the participants, all data were presented only at a population level, and not 
individually. Genetic polymorphisms indicate to some extent the risk for arsenic toxicity at a 
population level. Recently, this topic has been delved into in Bangladesh, an area where arsenic 
has been a public health concern. Participants were asked whether they wanted to receive this 
genetic information, and interestingly, they did (Tamayo et al., 2020). However, SNP data 
alone should not be used to estimate personal risk to arsenic exposure, particularly considering 
that other factors also contribute. It should also be noted that in low resource villages, as the 
ones included in this thesis, receiving this genetic information might be detrimental since 
individual actions might not be able to be carried out to decrease their exposure to arsenic. 
Nonetheless, advantages and disadvantages of sharing this information must be weighed 
beforehand, and a thorough communication plan is required to avoid misinterpretation of the 
results. 
5.8 PUBLIC HEALTH IMPLICATIONS 
Arsenic exposure is a major public health concern that affects millions of people around the 
world. In the case of the indigenous communities in the Andes included in this thesis, our 
contact with them and our research findings hopefully contribute to: 
• Addressing the lack of access to clean water, included within the Sustainable 
Development Goals of the United Nations. Data from Paper I can help plan the use of 
water sources by identifying which have less arsenic. 
• Reporting data on arsenic concentrations in water and human exposure can attract other 
organizations to help reduce the metal exposure via drinking water. 
• Supporting the introduction and development of new local policies concerning water 
treatments by contributing with exposure data. 
• Increasing the awareness about arsenic as a public health concern in the communities. 
It is worth noting that no clinical outcomes were included in this thesis to evaluate the toxicity 
of arsenic in these communities. This is due primarily to the lack of available clinical registries 
in these rural settings and the inherent limitations of the field work to perform longitudinal 
studies. Therefore, despite these populations showing a more efficient capacity to methylate 
arsenic, toxicity in these Andean populations cannot be excluded. In fact, as shown in Papers II 
and III, there are molecular signs related to arsenic toxicity that must not be overlooked. 
Furthermore, children, a vulnerable group to environmental pollutants, were not evaluated. As 
a result, even though these indigenous populations were described as efficient arsenic 






The conclusions of the work included in this thesis were the following: 
• Indigenous women living around Lake Poopó, Bolivia are exposed to inorganic arsenic 
presumably through drinking water. These women had low fractions of MMA and high 
fractions of DMA in urine indicating an efficient arsenic metabolism. Factors such as 
body weight, fish consumption, tobacco smoking, and ethnicity predicted the capacity 
to metabolize arsenic in these women. 
 
• Arsenic exposure, assessed in urine and blood, was associated with molecular signs of 
toxicity, and the association was modified by the arsenic metabolism efficiency 
– a known susceptibility factor. Arsenic exposure was associated with longer telomeres 
and higher mtDNAcn, particularly in women with a less efficient arsenic metabolism. 
A novel biomarker of lipid peroxidation, 4-HNE-MA, was positively associated with 
arsenic exposure. Conflicting results for 8-oxo-dG measured in urine accentuate the 
need to reconsider this biomarker of oxidative stress and the limitation of measuring 
both exposure and outcome in urine. 
 
• Arsenic exposure assessed in blood was associated with higher relative urinary levels 
of FASLG, and lower of SEZ6L, LYPD3, and TFPI2, four proteins putatively related 
to cancer processes. However, future research is required to confirm whether these 
proteins can be used as biomarkers of early cancer in relation to arsenic exposure. 
 
• Indigenous communities in the Bolivian Andes had genomic signs of positive selection 
near AS3MT, the main arsenic methylating enzyme in humans. The frequency of 
protective alleles near AS3MT associated with lower fractions of urinary MMA was the 
highest described so far. Taken together with their efficient arsenic metabolism 
phenotype, this supports the notion that exposure to arsenic during multiple generations 





7 FUTURE PERSPECTIVES 
In light of the current findings, additional efforts and attention should be focused towards: 
• Exploring further environmental and genetic factors that explain the efficient arsenic 
metabolism of these Andean populations. 
 
• Identifying the functional and potentially novel genetic variants near AS3MT that could 
have driven arsenic adaptation in these Andean populations. 
 
• Elucidating the potential additive effect of multiple non-coding AS3MT variants on the 
expression of AS3MT and its consequence on arsenic metabolism efficiency. 
 
• Monitoring and reducing the exposure to arsenic in the inhabitants of these villages. 
 
• Characterizing additional arsenic exposure routes in this arid region, such as inhalation 
of dust. 
 
• Investigating potential health effects of arsenic in Bolivian populations, such as the 
incidence of cancer, cardiovascular diseases, etc. 
 
• Performing longitudinal studies to link potential protein biomarkers measured in urine 






Working on this Ph.D. project has been one of the hardest adventures, personally and 
professionally, I have encountered so far. And yet, it has been an absolute pleasure to be part 
of this fascinating research, surrounded by the best teams I could have ever wished for. To 
everyone who I have met along this journey – thank you. When I came back to Sweden after 
my first trip to Bolivia in 2016, I remember telling my parents about it and describing it as a 
life-changing experience. And still today, I am certain this project has changed who I am as a 
researcher and as a person at levels I could have never imagined. It is incredible how small one 
can feel when we are exposed to unknown worlds to us, and how adaptable we realize we are 
once we are pushed out of our comfort zones. 
This work was carried out with financial support from Karolinska Institutet, the Eric Philip 
Sörensens Stiftelse, the Swedish Research Council, the Swedish International Development 
Cooperation Agency, the Genetics Institute at Universidad Mayor de San Andrés, the Institut 
de Recherche pour le Développement, and the Hydrosciences Montpellier Laboratory. 
To all the strong women I met in Bolivia. For all those times when we would shake hands 
before an interview, and you would be worried because my hands were so cold and wondered 
how I was handling the altitude; when I chocked on my saliva after chewing the coca leaves 
you invited me to in the middle of a meeting, and you just smiled back at me and we laughed; 
when you were scared of needles, and I tried to distract you with my colorful socks because I 
completely understand your fears. Thank you to everyone we met during our visits around Lake 
Poopó: for your warm welcome, and for believing and trusting us. It has been an honor for me 
to be able to work with you in your villages, get to know your culture, and hopefully contribute 
for you to get better drinking water quality. This is just the beginning. 
To my main supervisor, Karin Broberg. What an adventure, right? Despite, and maybe also 
because of, all the tough times we have been through together, I am extremely grateful for this 
opportunity and having had you as my supervisor. Thank you for trusting and believing in me. 
We always had each other’s backs – and that created the safest environment possible. You 
always had an open door for me – metaphorically and literally to all your homes – from the 
very first day. Sharing this journey with you has been a pleasure. It is impossible for me to 
imagine a more rewarding Ph.D. journey – thank you. 
Carina Schlebusch, my co-supervisor: I wish the academic world were full of more people 
like you, and the non-academic world as well. Your curiosity and passion for your work, and 
your dedication to your team is inspiring. I still remember the days when I was haunting EBC 
with a sad face because I could not get any results, and you genuinely cared for me. Thank you 
for sharing your incredible knowledge with me, and for being so caring. 
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